Loading...

Lewis Lanier, PhD

TitleProfessor
SchoolUCSF School of Medicine
DepartmentMicrobiology and Immunology
AddressCore Campus, HSE
San Francisco CA 94143
Phone415-514-0829
vCardDownload vCard
    Other Positions
    TitleChair, Microbiology and Immunology


    Collapse Biography 
    Collapse Education and Training
    Virginia TechB.S.1975Biology
    University of North Carolina Chapel HillPh.D.1978Microbiology and Immunology
    Collapse Awards and Honors
    University of California San Francisco2013J. Michael Bishop MD Distinguished Professor
    University of North Carolina - Chapel Hill2013Distinguished UNC Alumnus Award
    American Academy of Arts and Sciences2011Member
    University of California San Francisco2011Faculty Research Lecture - Basic Science
    American Academy of Microbiology2011Fellow
    National Academy of Sciences2010Member
    American Association of Immunologists2006  - 2007President
    American Society for Histocompatibility & Immunogenetics2005Rose Payne Award
    American Cancer Society2003Research Professor
    Cancer Research Institute2002William B Coley Award for Distinguished Research in Basic and Tumor
    American Association of Immunologists 2001Distinguished Service Award
    Becton Dickinson1990Research Fellow
    Damon Runyon - Walter Winchell Cancer Fund1979  - 1981Postdoctoral Fellow

    Collapse Overview 
    Collapse Overview
    Natural killer (NK) cells are a type of white blood cell that provides protection against microbial pathogens and tumors. Since the early 1980’s, our lab has investigated how NK cells distinguish between normal healthy cells and cells that are transformed or infected with viruses. NK cells express a diverse array of inhibitory and activating receptors on their cells surface that bind to ligands expressed on the cell surface of potential target cells. When encountering healthy cells, signals transmitted by inhibitory NK receptors dominate and prevent autoimmunity, whereas the loss of ligands for the inhibitory receptors or the upregulation of ligands for the activating NK receptors on infected or transformed cells allows NK cells to kill these abnormal cells and secrete cytokine that influence the subsequent response by T cells and B cells. We have developed mouse models systems in which key signaling molecules such as DAP10 and DAP12 have been ablated to explore the physiological role of these NK receptors in resistance to viral infections (cytomegalovirus, poxviruses, and influenza) and primary tumorigenesis.


    Collapse Research 
    Collapse Research Activities and Funding
    Human natural killer cell recognition of cytomegalovirus
    NIH/NIAID R21AI108860Jun 16, 2014 - May 31, 2016
    Role: Principal Investigator
    UCSF DVS CyTOF Mass Cytometer
    NIH S10OD018040May 1, 2014 - Apr 30, 2015
    Role: Principal Investigator
    13th International Meeting of the Society for Natural Immunity April 20-24, 2012
    NIH/NIAID R13AI098278Mar 1, 2012 - Feb 28, 2013
    Role: Principal Investigator
    Bay Area Hepatitis C Cooperative Research Center
    NIH U19AI088790Jun 15, 2010 - May 31, 2015
    Role: Co-Investigator
    Human Natural Killer Cell Biology
    NIH/NIAID P01AI064520Sep 16, 2005 - Feb 28, 2011
    Role: Co-Investigator
    Systems Approach to Innate Immunity-Inflammation-Sepsis
    NIH U54AI054523Sep 30, 2002 - Jul 31, 2008
    Role: Co-Investigator
    NK Cell Biology
    NIH/NCI R01CA095137Apr 1, 2002 - Jan 31, 2015
    Role: Principal Investigator
    Biology of Leukocyte Regulatory Receptor
    NIH/NIAID R13AI051933Apr 1, 2002 - Mar 31, 2003
    Role: Principal Investigator
    NK and T Cell Costimulation by NKG2D/DAP10
    NIH/NIAID R37AI066897Mar 1, 2001 - Feb 29, 2016
    Role: Principal Investigator
    NK AND T CELL COSTIMULATION BY NKG2D/DAP10
    NIH/NCI R01CA089189Feb 1, 2001 - Jan 31, 2006
    Role: Principal Investigator
    NK Memory
    NIH/NIAID R01AI068129Jan 9, 2001 - Mar 31, 2021
    Role: Principal Investigator
    NK CELL RECEPTORS AND THEIR LIGANDS
    NIH/NCI R01CA089294Jan 9, 2001 - Dec 31, 2005
    Role: Principal Investigator
    Cancer Center Support Grant
    NIH/NCI P30CA082103Aug 5, 1999 - May 31, 2018
    Role: Co-Investigator

    Collapse ORNG Applications 
    Collapse Websites
    Collapse In The News
    Collapse Global Health

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Lam VC, Lanier L. NK cells in host responses to viral infections. Curr Opin Immunol. 2016 Dec 13; 44:43-51. PMID: 27984782.
      View in: PubMed
    2. Nabekura T, Lanier L. Tracking the fate of antigen-specific versus cytokine-activated natural killer cells after cytomegalovirus infection. J Exp Med. 2016 Nov 14; 213(12):2745-2758. PMID: 27810928.
      View in: PubMed
    3. Nabekura T, Lanier L. Activating Receptors for Self-MHC Class I Enhance Effector Functions and Memory Differentiation of NK Cells during Mouse Cytomegalovirus Infection. Immunity. 2016 Jul 19; 45(1):74-82. PMID: 27438766.
      View in: PubMed
    4. Spits H, Bernink JH, Lanier L. NK cells and type 1 innate lymphoid cells: partners in host defense. Nat Immunol. 2016 Jun 21; 17(7):758-64. PMID: 27328005.
      View in: PubMed
    5. Cerwenka A, Lanier L. Natural killer cell memory in infection, inflammation and cancer. Nat Rev Immunol. 2016 Feb; 16(2):112-23. PMID: 26806484.
      View in: PubMed
    6. Madera S, Rapp M, Firth MA, Beilke JN, Lanier L, Sun JC. Type I IFN promotes NK cell expansion during viral infection by protecting NK cells against fratricide. J Exp Med. 2016 Feb 8; 213(2):225-33. PMID: 26755706.
      View in: PubMed
    7. Hendricks DW, Min-Oo G, Lanier L. Sweet Is the Memory of Past Troubles: NK Cells Remember. Curr Top Microbiol Immunol. 2016; 395:147-71. PMID: 26099194.
      View in: PubMed
    8. Morvan MG, Lanier L. NK cells and cancer: you can teach innate cells new tricks. Nat Rev Cancer. 2015 Dec 23; 16(1):7-19. PMID: 26694935.
      View in: PubMed
    9. Guan Z, Kuhn JA, Wang X, Colquitt B, Solorzano C, Vaman S, Guan AK, Evans-Reinsch Z, Braz J, Devor M, Abboud-Werner SL, Lanier L, Lomvardas S, Basbaum AI. Injured sensory neuron-derived CSF1 induces microglial proliferation and DAP12-dependent pain. Nat Neurosci. 2016 Jan; 19(1):94-101. PMID: 26642091.
      View in: PubMed
    10. O'Sullivan TE, Sun JC, Lanier L. Natural Killer Cell Memory. Immunity. 2015 Oct 20; 43(4):634-45. PMID: 26488815; PMCID: PMC4621966 [Available on 10/20/16].
    11. Huang X, Li J, Dorta-Estremera S, Di Domizio J, Anthony SM, Watowich SS, Popkin D, Liu Z, Brohawn P, Yao Y, Schluns KS, Lanier L, Cao W. Neutrophils Regulate Humoral Autoimmunity by Restricting Interferon-? Production via the Generation of Reactive Oxygen Species. Cell Rep. 2015 Aug 18; 12(7):1120-32. PMID: 26257170; PMCID: PMC4545388 [Available on 08/18/16].
    12. Lanier L. NKG2D Receptor and Its Ligands in Host Defense. Cancer Immunol Res. 2015 Jun; 3(6):575-82. PMID: 26041808; PMCID: PMC4457299 [Available on 06/01/16].
    13. Nabekura T, Girard JP, Lanier L. IL-33 receptor ST2 amplifies the expansion of NK cells and enhances host defense during mouse cytomegalovirus infection. J Immunol. 2015 Jun 15; 194(12):5948-52. PMID: 25926677; PMCID: PMC4458425 [Available on 06/15/16].
    14. Lee J, Zhang T, Hwang I, Kim A, Nitschke L, Kim M, Scott JM, Kamimura Y, Lanier L, Kim S. Epigenetic modification and antibody-dependent expansion of memory-like NK cells in human cytomegalovirus-infected individuals. Immunity. 2015 Mar 17; 42(3):431-42. PMID: 25786175; PMCID: PMC4537797 [Available on 03/17/16].
    15. Tanimura K, Jin H, Suenaga T, Morikami S, Arase N, Kishida K, Hirayasu K, Kohyama M, Ebina Y, Yasuda S, Horita T, Takasugi K, Ohmura K, Yamamoto K, Katayama I, Sasazuki T, Lanier L, Atsumi T, Yamada H, Arase H. ß2-Glycoprotein I/HLA class II complexes are novel autoantigens in antiphospholipid syndrome. Blood. 2015 Apr 30; 125(18):2835-44. PMID: 25733579; PMCID: PMC4424631 [Available on 04/30/16].
    16. Kamimura Y, Lanier L. Homeostatic control of memory cell progenitors in the natural killer cell lineage. Cell Rep. 2015 Jan 13; 10(2):280-91. PMID: 25578733; PMCID: PMC4359047 [Available on 01/13/16].
    17. Min-Oo G, Lanier L. Cytomegalovirus generates long-lived antigen-specific NK cells with diminished bystander activation to heterologous infection. J Exp Med. 2014 Dec 15; 211(13):2669-80. PMID: 25422494; PMCID: PMC4267234.
    18. Nabekura T, Lanier L. Antigen-specific expansion and differentiation of natural killer cells by alloantigen stimulation. J Exp Med. 2014 Nov 17; 211(12):2455-65. PMID: 25366966; PMCID: PMC4235640.
    19. Weinger JG, Plaisted WC, Maciejewski SM, Lanier L, Walsh CM, Lane TE. Activating receptor NKG2D targets RAE-1-expressing allogeneic neural precursor cells in a viral model of multiple sclerosis. Stem Cells. 2014 Oct; 32(10):2690-701. PMID: 24898518; PMCID: PMC4165828.
    20. Lanier L. Just the FACS. J Immunol. 2014 Sep 1; 193(5):2043-4. PMID: 25128548.
      View in: PubMed
    21. Crane CA, Austgen K, Haberthur K, Hofmann C, Moyes KW, Avanesyan L, Fong L, Campbell MJ, Cooper S, Oakes SA, Parsa AT, Lanier L. Immune evasion mediated by tumor-derived lactate dehydrogenase induction of NKG2D ligands on myeloid cells in glioblastoma patients. Proc Natl Acad Sci U S A. 2014 Sep 2; 111(35):12823-8. PMID: 25136121; PMCID: PMC4156766.
    22. Du J, Lopez-Verges S, Pitcher BN, Johnson J, Jung SH, Zhou L, Hsu K, Czuczman MS, Cheson B, Kaplan L, Lanier L, Venstrom JM. CALGB 150905 (Alliance): rituximab broadens the antilymphoma response by activating unlicensed NK cells. Cancer Immunol Res. 2014 Sep; 2(9):878-89. PMID: 24958280; PMCID: PMC4264658.
    23. Min-Oo G, Bezman NA, Madera S, Sun JC, Lanier L. Proapoptotic Bim regulates antigen-specific NK cell contraction and the generation of the memory NK cell pool after cytomegalovirus infection. J Exp Med. 2014 Jun 30; 211(7):1289-96. PMID: 24958849; PMCID: PMC4076589.
    24. Orbelyan GA, Tang F, Sally B, Solus J, Meresse B, Ciszewski C, Grenier JC, Barreiro LB, Lanier L, Jabri B. Human NKG2E is expressed and forms an intracytoplasmic complex with CD94 and DAP12. J Immunol. 2014 Jul 15; 193(2):610-6. PMID: 24935923; PMCID: PMC4091631.
    25. Kalinowski A, Ueki I, Min-Oo G, Ballon-Landa E, Knoff D, Galen B, Lanier L, Nadel JA, Koff JL. EGFR activation suppresses respiratory virus-induced IRF1-dependent CXCL10 production. Am J Physiol Lung Cell Mol Physiol. 2014 Jul 15; 307(2):L186-96. PMID: 24838750; PMCID: PMC4101792.
    26. Kamimura Y, Lanier L. Rapid and sequential quantitation of salivary gland-associated mouse cytomegalovirus in oral lavage. J Virol Methods. 2014 Sep 1; 205:53-6. PMID: 24747009.
      View in: PubMed
    27. Hendricks DW, Balfour HH, Dunmire SK, Schmeling DO, Hogquist KA, Lanier L. Cutting edge: NKG2C(hi)CD57+ NK cells respond specifically to acute infection with cytomegalovirus and not Epstein-Barr virus. J Immunol. 2014 May 15; 192(10):4492-6. PMID: 24740502; PMCID: PMC4013527.
    28. Jin H, Arase N, Hirayasu K, Kohyama M, Suenaga T, Saito F, Tanimura K, Matsuoka S, Ebina K, Shi K, Toyama-Sorimachi N, Yasuda S, Horita T, Hiwa R, Takasugi K, Ohmura K, Yoshikawa H, Saito T, Atsumi T, Sasazuki T, Katayama I, Lanier L, Arase H. Autoantibodies to IgG/HLA class II complexes are associated with rheumatoid arthritis susceptibility. Proc Natl Acad Sci U S A. 2014 Mar 11; 111(10):3787-92. PMID: 24567378; PMCID: PMC3956152.
    29. Lanier L. Of snowflakes and natural killer cell subsets. Nat Biotechnol. 2014 Feb; 32(2):140-2. PMID: 24509762.
      View in: PubMed
    30. Nabekura T, Kanaya M, Shibuya A, Fu G, Gascoigne NR, Lanier L. Costimulatory molecule DNAM-1 is essential for optimal differentiation of memory natural killer cells during mouse cytomegalovirus infection. Immunity. 2014 Feb 20; 40(2):225-34. PMID: 24440149; PMCID: PMC3943894.
    31. Dangl JL, Lanier L. Founding father of FACS: Professor Leonard A. Herzenberg (1931–2013). Proc Natl Acad Sci U S A. 2013 Dec 24; 110(52):20848-9. PMID: 24344298; PMCID: PMC3876245.
    32. Milush JM, López-Vergès S, York VA, Deeks SG, Martin JN, Hecht FM, Lanier L, Nixon DF. CD56negCD16? NK cells are activated mature NK cells with impaired effector function during HIV-1 infection. Retrovirology. 2013; 10:158. PMID: 24351015; PMCID: PMC3892122.
    33. Hartigan-O'Connor DJ, Lin D, Ryan JC, Shvachko VA, Cozen ML, Segal MR, Terrault NA, Lanier L, Manos MM, McCune JM. Monocyte activation by interferon a is associated with failure to achieve a sustained virologic response after treatment for hepatitis C virus infection. J Infect Dis. 2014 May 15; 209(10):1602-12. PMID: 24325966; PMCID: PMC3997582.
    34. Kim CC, Lanier L. Beyond the transcriptome: completion of act one of the Immunological Genome Project. Curr Opin Immunol. 2013 Oct; 25(5):593-7. PMID: 24168965; PMCID: PMC3855358.
    35. Ueki IF, Min-Oo G, Kalinowski A, Ballon-Landa E, Lanier L, Nadel JA, Koff JL. Respiratory virus-induced EGFR activation suppresses IRF1-dependent interferon ? and antiviral defense in airway epithelium. J Exp Med. 2013 Sep 23; 210(10):1929-36. PMID: 23999497; PMCID: PMC3782052.
    36. Co EC, Gormley M, Kapidzic M, Rosen DB, Scott MA, Stolp HA, McMaster M, Lanier L, Bárcena A, Fisher SJ. Maternal decidual macrophages inhibit NK cell killing of invasive cytotrophoblasts during human pregnancy. Biol Reprod. 2013 Jun; 88(6):155. PMID: 23553431; PMCID: PMC4070869.
    37. Hosomi S, Chen Z, Baker K, Chen L, Huang YH, Olszak T, Zeissig S, Wang JH, Mandelboim O, Beauchemin N, Lanier L, Blumberg RS. CEACAM1 on activated NK cells inhibits NKG2D-mediated cytolytic function and signaling. Eur J Immunol. 2013 Sep; 43(9):2473-83. PMID: 23696226; PMCID: PMC3775953.
    38. Mingueneau M, Kreslavsky T, Gray D, Heng T, Cruse R, Ericson J, Bendall S, Spitzer MH, Nolan GP, Kobayashi K, von Boehmer H, Mathis D, Benoist C. The transcriptional landscape of aß T cell differentiation. Nat Immunol. 2013 Jun; 14(6):619-32. PMID: 23644507; PMCID: PMC3660436.
    39. Beaulieu AM, Bezman NA, Lee JE, Matloubian M, Sun JC, Lanier L. MicroRNA function in NK-cell biology. Immunol Rev. 2013 May; 253(1):40-52. PMID: 23550637; PMCID: PMC3621029.
    40. Jojic V, Shay T, Sylvia K, Zuk O, Sun X, Kang J, Regev A, Koller D. Identification of transcriptional regulators in the mouse immune system. Nat Immunol. 2013 Jun; 14(6):633-43. PMID: 23624555; PMCID: PMC3690947.
    41. Zawislak CL, Beaulieu AM, Loeb GB, Karo J, Canner D, Bezman NA, Lanier L, Rudensky AY, Sun JC. Stage-specific regulation of natural killer cell homeostasis and response against viral infection by microRNA-155. Proc Natl Acad Sci U S A. 2013 Apr 23; 110(17):6967-72. PMID: 23572582; PMCID: PMC3637707.
    42. Min-Oo G, Kamimura Y, Hendricks DW, Nabekura T, Lanier L. Natural killer cells: walking three paths down memory lane. Trends Immunol. 2013 Jun; 34(6):251-8. PMID: 23499559; PMCID: PMC3674190.
    43. Lanier L. Shades of grey--the blurring view of innate and adaptive immunity. Nat Rev Immunol. 2013 Feb; 13(2):73-4. PMID: 23469373.
      View in: PubMed
    44. Jiang Y, Arase N, Kohyama M, Hirayasu K, Suenaga T, Jin H, Matsumoto M, Shida K, Lanier L, Saito T, Arase H. Transport of misfolded endoplasmic reticulum proteins to the cell surface by MHC class II molecules. Int Immunol. 2013 Apr; 25(4):235-46. PMID: 23334921; PMCID: PMC3597850.
    45. Batista MD, Ho EL, Kuebler PJ, Milush JM, Lanier L, Kallas EG, York VA, Chang D, Liao W, Unemori P, Leslie KS, Maurer T, Nixon DF. Skewed distribution of natural killer cells in psoriasis skin lesions. Exp Dermatol. 2013 Jan; 22(1):64-6. PMID: 23278897; PMCID: PMC3777400.
    46. Benoist C, Lanier L, Merad M, Mathis D. Consortium biology in immunology: the perspective from the Immunological Genome Project. Nat Rev Immunol. 2012 Oct; 12(10):734-40. PMID: 22955842.
      View in: PubMed
    47. Bezman NA, Kim CC, Sun JC, Min-Oo G, Hendricks DW, Kamimura Y, Best JA, Goldrath AW, Lanier L. Molecular definition of the identity and activation of natural killer cells. Nat Immunol. 2012 Oct; 13(10):1000-9. PMID: 22902830; PMCID: PMC3572860.
    48. Thomas MF, Abdul-Wajid S, Panduro M, Babiarz JE, Rajaram M, Woodruff P, Lanier L, Heissmeyer V, Ansel KM. Eri1 regulates microRNA homeostasis and mouse lymphocyte development and antiviral function. Blood. 2012 Jul 5; 120(1):130-42. PMID: 22613798; PMCID: PMC3390952.
    49. Beilke JN, Meagher CT, Hosiawa K, Champsaur M, Bluestone JA, Lanier L. NK cells are not required for spontaneous autoimmune diabetes in NOD mice. PLoS One. 2012; 7(4):e36011. PMID: 22558306; PMCID: PMC3338490.
    50. Park CY, Jeker LT, Carver-Moore K, Oh A, Liu HJ, Cameron R, Richards H, Li Z, Adler D, Yoshinaga Y, Martinez M, Nefadov M, Abbas AK, Weiss A, Lanier L, de Jong PJ, Bluestone JA, Srivastava D, McManus MT. A resource for the conditional ablation of microRNAs in the mouse. Cell Rep. 2012 Apr 19; 1(4):385-91. PMID: 22570807.
      View in: PubMed
    51. Sun JC, Madera S, Bezman NA, Beilke JN, Kaplan MH, Lanier L. Proinflammatory cytokine signaling required for the generation of natural killer cell memory. J Exp Med. 2012 May 7; 209(5):947-54. PMID: 22493516; PMCID: PMC3348098.
    52. Ndhlovu LC, Lopez-Vergès S, Barbour JD, Jones RB, Jha AR, Long BR, Schoeffler EC, Fujita T, Nixon DF, Lanier L. Tim-3 marks human natural killer cell maturation and suppresses cell-mediated cytotoxicity. Blood. 2012 Apr 19; 119(16):3734-43. PMID: 22383801; PMCID: PMC3335380.
    53. Nielsen N, Ødum N, Ursø B, Lanier L, Spee P. Cytotoxicity of CD56(bright) NK cells towards autologous activated CD4+ T cells is mediated through NKG2D, LFA-1 and TRAIL and dampened via CD94/NKG2A. PLoS One. 2012; 7(2):e31959. PMID: 22384114; PMCID: PMC3284517.
    54. Tietze JK, Wilkins DE, Sckisel GD, Bouchlaka MN, Alderson KL, Weiss JM, Ames E, Bruhn KW, Craft N, Wiltrout RH, Longo DL, Lanier L, Blazar BR, Redelman D, Murphy WJ. Delineation of antigen-specific and antigen-nonspecific CD8(+) memory T-cell responses after cytokine-based cancer immunotherapy. Blood. 2012 Mar 29; 119(13):3073-83. PMID: 22251483; PMCID: PMC3321869.
    55. Foley B, Cooley S, Verneris MR, Pitt M, Curtsinger J, Luo X, Lopez-Vergès S, Lanier L, Weisdorf D, Miller JS. Cytomegalovirus reactivation after allogeneic transplantation promotes a lasting increase in educated NKG2C+ natural killer cells with potent function. Blood. 2012 Mar 15; 119(11):2665-74. PMID: 22180440; PMCID: PMC3311280.
    56. Chen Z, Chen L, Baker K, Olszak T, Zeissig S, Huang YH, Kuo TT, Mandelboim O, Beauchemin N, Lanier L, Blumberg RS. CEACAM1 dampens antitumor immunity by down-regulating NKG2D ligand expression on tumor cells. J Exp Med. 2011 Dec 19; 208(13):2633-40. PMID: 22143889; PMCID: PMC3244030.
    57. Bezman NA, Chakraborty T, Bender T, Lanier L. miR-150 regulates the development of NK and iNKT cells. J Exp Med. 2011 Dec 19; 208(13):2717-31. PMID: 22124110; PMCID: PMC3244033.
    58. Sun JC, Lanier L. NK cell development, homeostasis and function: parallels with CD8? T cells. Nat Rev Immunol. 2011 Oct; 11(10):645-57. PMID: 21869816; PMCID: PMC4408539.
    59. Lopez-Vergès S, Milush JM, Schwartz BS, Pando MJ, Jarjoura J, York VA, Houchins JP, Miller S, Kang SM, Norris PJ, Nixon DF, Lanier L. Expansion of a unique CD57?NKG2Chi natural killer cell subset during acute human cytomegalovirus infection. Proc Natl Acad Sci U S A. 2011 Sep 6; 108(36):14725-32. PMID: 21825173; PMCID: PMC3169160.
    60. Nakano-Yokomizo T, Tahara-Hanaoka S, Nakahashi-Oda C, Nabekura T, Tchao NK, Kadosaki M, Totsuka N, Kurita N, Nakamagoe K, Tamaoka A, Takai T, Yasui T, Kikutani H, Honda S, Shibuya K, Lanier L, Shibuya A. The immunoreceptor adapter protein DAP12 suppresses B lymphocyte-driven adaptive immune responses. J Exp Med. 2011 Aug 1; 208(8):1661-71. PMID: 21727189; PMCID: PMC3149228.
    61. Fang M, Orr MT, Spee P, Egebjerg T, Lanier L, Sigal LJ. CD94 is essential for NK cell-mediated resistance to a lethal viral disease. Immunity. 2011 Apr 22; 34(4):579-89. PMID: 21439856; PMCID: PMC3081423.
    62. Barao I, Alvarez M, Ames E, Orr MT, Stefanski HE, Blazar BR, Lanier L, Anderson SK, Redelman D, Murphy WJ. Mouse Ly49G2+ NK cells dominate early responses during both immune reconstitution and activation independently of MHC. Blood. 2011 Jun 30; 117(26):7032-41. PMID: 21498673; PMCID: PMC3143551.
    63. Sun JC, Lopez-Verges S, Kim CC, DeRisi JL, Lanier L. NK cells and immune "memory". J Immunol. 2011 Feb 15; 186(4):1891-7. PMID: 21289313; PMCID: PMC4410097.
    64. Sun JC, Beilke JN, Bezman NA, Lanier L. Homeostatic proliferation generates long-lived natural killer cells that respond against viral infection. J Exp Med. 2011 Feb 14; 208(2):357-68. PMID: 21262959; PMCID: PMC3039854.
    65. Hesslein DG, Palacios EH, Sun JC, Beilke JN, Watson SR, Weiss A, Lanier L. Differential requirements for CD45 in NK-cell function reveal distinct roles for Syk-family kinases. Blood. 2011 Mar 17; 117(11):3087-95. PMID: 21245479; PMCID: PMC3062311.
    66. Kogure A, Shiratori I, Wang J, Lanier L, Arase H. PANP is a novel O-glycosylated PILRa ligand expressed in neural tissues. Biochem Biophys Res Commun. 2011 Feb 18; 405(3):428-33. PMID: 21241660; PMCID: PMC4089865.
    67. Vivier E, Raulet DH, Moretta A, Caligiuri MA, Zitvogel L, Lanier L, Yokoyama WM, Ugolini S. Innate or adaptive immunity? The example of natural killer cells. Science. 2011 Jan 7; 331(6013):44-9. PMID: 21212348; PMCID: PMC3089969.
    68. Orr MT, Lanier L. Natural killer cell licensing during viral infection. Adv Exp Med Biol. 2011; 780:37-44. PMID: 21842363.
      View in: PubMed
    69. Hesslein DG, Lanier L. Transcriptional control of natural killer cell development and function. Adv Immunol. 2011; 109:45-85. PMID: 21569912.
      View in: PubMed
    70. Orr MT, Lanier L. Inhibitory Ly49 receptors on mouse natural killer cells. Curr Top Microbiol Immunol. 2011; 350:67-87. PMID: 20680808.
      View in: PubMed
    71. Sun JC, Lanier L. Versatility in NK cell memory. Immunol Cell Biol. 2011 Mar; 89(3):327-9. PMID: 21173784; PMCID: PMC4406234.
    72. Orr MT, Wu J, Fang M, Sigal LJ, Spee P, Egebjerg T, Dissen E, Fossum S, Phillips JH, Lanier L. Development and function of CD94-deficient natural killer cells. PLoS One. 2010; 5(12):e15184. PMID: 21151939; PMCID: PMC2997080.
    73. Babic M, Pyzik M, Zafirova B, Mitrovic M, Butorac V, Lanier L, Krmpotic A, Vidal SM, Jonjic S. Cytomegalovirus immunoevasin reveals the physiological role of "missing self" recognition in natural killer cell dependent virus control in vivo. J Exp Med. 2010 Nov 22; 207(12):2663-73. PMID: 21078887; PMCID: PMC2989764.
    74. Orr MT, Lanier L. Natural killer cell education and tolerance. Cell. 2010 Sep 17; 142(6):847-56. PMID: 20850008; PMCID: PMC2945212.
    75. Bezman NA, Cedars E, Steiner DF, Blelloch R, Hesslein DG, Lanier L. Distinct requirements of microRNAs in NK cell activation, survival, and function. J Immunol. 2010 Oct 1; 185(7):3835-46. PMID: 20805417; PMCID: PMC2943981.
    76. Beilke JN, Benjamin J, Lanier L. The requirement for NKG2D in NK cell-mediated rejection of parental bone marrow grafts is determined by MHC class I expressed by the graft recipient. Blood. 2010 Dec 9; 116(24):5208-16. PMID: 20736452; PMCID: PMC3012538.
    77. Lopez-Vergès S, Milush JM, Pandey S, York VA, Arakawa-Hoyt J, Pircher H, Norris PJ, Nixon DF, Lanier L. CD57 defines a functionally distinct population of mature NK cells in the human CD56dimCD16+ NK-cell subset. Blood. 2010 Nov 11; 116(19):3865-74. PMID: 20733159; PMCID: PMC2981540.
    78. Orr MT, Beilke JN, Proekt I, Lanier L. Natural killer cells in NOD.NK1.1 mice acquire cytolytic function during viral infection and provide protection against cytomegalovirus. Proc Natl Acad Sci U S A. 2010 Sep 7; 107(36):15844-9. PMID: 20733071; PMCID: PMC2936652.
    79. Sun JC, Beilke JN, Lanier L. Immune memory redefined: characterizing the longevity of natural killer cells. Immunol Rev. 2010 Jul; 236:83-94. PMID: 20636810; PMCID: PMC2907527.
    80. Champsaur M, Beilke JN, Ogasawara K, Koszinowski UH, Jonjic S, Lanier L. Intact NKG2D-independent function of NK cells chronically stimulated with the NKG2D ligand Rae-1. J Immunol. 2010 Jul 1; 185(1):157-65. PMID: 20530257; PMCID: PMC4102003.
    81. Champsaur M, Lanier L. Effect of NKG2D ligand expression on host immune responses. Immunol Rev. 2010 May; 235(1):267-85. PMID: 20536569; PMCID: PMC2885032.
    82. Koth LL, Cambier CJ, Ellwanger A, Solon M, Hou L, Lanier L, Abram CL, Hamerman JA, Woodruff PG. DAP12 is required for macrophage recruitment to the lung in response to cigarette smoke and chemotaxis toward CCL2. J Immunol. 2010 Jun 1; 184(11):6522-8. PMID: 20421649; PMCID: PMC4091814.
    83. Orr MT, Murphy WJ, Lanier L. 'Unlicensed' natural killer cells dominate the response to cytomegalovirus infection. Nat Immunol. 2010 Apr; 11(4):321-7. PMID: 20190757; PMCID: PMC2842453.
    84. Crane CA, Han SJ, Barry JJ, Ahn BJ, Lanier L, Parsa AT. TGF-beta downregulates the activating receptor NKG2D on NK cells and CD8+ T cells in glioma patients. Neuro Oncol. 2010 Jan; 12(1):7-13. PMID: 20150362; PMCID: PMC2940557.
    85. Wang J, Fan Q, Satoh T, Arii J, Lanier L, Spear PG, Kawaguchi Y, Arase H. Binding of herpes simplex virus glycoprotein B (gB) to paired immunoglobulin-like type 2 receptor alpha depends on specific sialylated O-linked glycans on gB. J Virol. 2009 Dec; 83(24):13042-5. PMID: 19812165; PMCID: PMC2786847.
    86. Jenne CN, Enders A, Rivera R, Watson SR, Bankovich AJ, Pereira JP, Xu Y, Roots CM, Beilke JN, Banerjee A, Reiner SL, Miller SA, Weinmann AS, Goodnow CC, Lanier L, Cyster JG, Chun J. T-bet-dependent S1P5 expression in NK cells promotes egress from lymph nodes and bone marrow. J Exp Med. 2009 Oct 26; 206(11):2469-81. PMID: 19808259; PMCID: PMC2768857.
    87. Milush JM, Long BR, Snyder-Cappione JE, Cappione AJ, York VA, Ndhlovu LC, Lanier L, Michaëlsson J, Nixon DF. Functionally distinct subsets of human NK cells and monocyte/DC-like cells identified by coexpression of CD56, CD7, and CD4. Blood. 2009 Nov 26; 114(23):4823-31. PMID: 19805616; PMCID: PMC2786291.
    88. Long BR, Erickson AE, Chapman JM, Barbour JD, Vu BA, Ho EL, Lanier L, Sauer MM, Carvalho KI, Nixon DF, Kallas EG. Increased number and function of natural killer cells in human immunodeficiency virus 1-positive subjects co-infected with herpes simplex virus 2. Immunology. 2010 Feb; 129(2):186-96. PMID: 19824915; PMCID: PMC2814461.
    89. Sun JC, Lanier L. Natural killer cells remember: an evolutionary bridge between innate and adaptive immunity? Eur J Immunol. 2009 Aug; 39(8):2059-64. PMID: 19637199; PMCID: PMC2819266.
    90. Sun JC, Ma A, Lanier L. Cutting edge: IL-15-independent NK cell response to mouse cytomegalovirus infection. J Immunol. 2009 Sep 1; 183(5):2911-4. PMID: 19648279; PMCID: PMC2745285.
    91. Cao W, Bover L, Cho M, Wen X, Hanabuchi S, Bao M, Rosen DB, Wang YH, Shaw JL, Du Q, Li C, Arai N, Yao Z, Lanier L, Liu YJ. Regulation of TLR7/9 responses in plasmacytoid dendritic cells by BST2 and ILT7 receptor interaction. J Exp Med. 2009 Jul 6; 206(7):1603-14. PMID: 19564354; PMCID: PMC2715090.
    92. Lanier L, Sun JC. Do the terms innate and adaptive immunity create conceptual barriers? Nat Rev Immunol. 2009 May; 9(5):302-3. PMID: 19396937; PMCID: PMC2844347.
    93. Orr MT, Sun JC, Hesslein DG, Arase H, Phillips JH, Takai T, Lanier L. Ly49H signaling through DAP10 is essential for optimal natural killer cell responses to mouse cytomegalovirus infection. J Exp Med. 2009 Apr 13; 206(4):807-17. PMID: 19332875; PMCID: PMC2715124.
    94. Kielczewska A, Pyzik M, Sun T, Krmpotic A, Lodoen MB, Munks MW, Babic M, Hill AB, Koszinowski UH, Jonjic S, Lanier L, Vidal SM. Ly49P recognition of cytomegalovirus-infected cells expressing H2-Dk and CMV-encoded m04 correlates with the NK cell antiviral response. J Exp Med. 2009 Mar 16; 206(3):515-23. PMID: 19255146; PMCID: PMC2699136.
    95. Buhtoiarov IN, Rakhmilevich AL, Lanier L, Ranheim EA, Sondel PM. Naive mouse macrophages become activated following recognition of L5178Y lymphoma cells via concurrent ligation of CD40, NKG2D, and CD18 molecules. J Immunol. 2009 Feb 15; 182(4):1940-53. PMID: 19201847; PMCID: PMC2757113.
    96. Sun JC, Beilke JN, Lanier L. Adaptive immune features of natural killer cells. Nature. 2009 Jan 29; 457(7229):557-61. PMID: 19136945; PMCID: PMC2674434.
    97. Sun JC, Lanier L. The Natural Selection of Herpesviruses and Virus-Specific NK Cell Receptors. Viruses. 2009; 1(3):362. PMID: 20151027.
      View in: PubMed
    98. Lanier L. DAP10- and DAP12-associated receptors in innate immunity. Immunol Rev. 2009 Jan; 227(1):150-60. PMID: 19120482; PMCID: PMC2794881.
    99. Sun JC, Lanier L. Cutting edge: viral infection breaks NK cell tolerance to "missing self". J Immunol. 2008 Dec 1; 181(11):7453-7. PMID: 19017932; PMCID: PMC2587071.
    100. Kim CC, Parikh S, Sun JC, Myrick A, Lanier L, Rosenthal PJ, DeRisi JL. Experimental malaria infection triggers early expansion of natural killer cells. Infect Immun. 2008 Dec; 76(12):5873-82. PMID: 18824529; PMCID: PMC2583561.
    101. Saether PC, Westgaard IH, Hoelsbrekken SE, Benjamin J, Lanier L, Fossum S, Dissen E. KLRE/I1 and KLRE/I2: a novel pair of heterodimeric receptors that inversely regulate NK cell cytotoxicity. J Immunol. 2008 Sep 1; 181(5):3177-82. PMID: 18713988; PMCID: PMC2577148.
    102. Sun JC, Lanier L. Tolerance of NK cells encountering their viral ligand during development. J Exp Med. 2008 Aug 4; 205(8):1819-28. PMID: 18606858; PMCID: PMC2525590.
    103. Rosen DB, Cao W, Avery DT, Tangye SG, Liu YJ, Houchins JP, Lanier L. Functional consequences of interactions between human NKR-P1A and its ligand LLT1 expressed on activated dendritic cells and B cells. J Immunol. 2008 May 15; 180(10):6508-17. PMID: 18453569; PMCID: PMC2577150.
    104. Lanier L. Up on the tightrope: natural killer cell activation and inhibition. Nat Immunol. 2008 May; 9(5):495-502. PMID: 18425106; PMCID: PMC2669298.
    105. Satoh T, Arii J, Suenaga T, Wang J, Kogure A, Uehori J, Arase N, Shiratori I, Tanaka S, Kawaguchi Y, Spear PG, Lanier L, Arase H. PILRalpha is a herpes simplex virus-1 entry coreceptor that associates with glycoprotein B. Cell. 2008 Mar 21; 132(6):935-44. PMID: 18358807; PMCID: PMC2394663.
    106. Lanier L. Evolutionary struggles between NK cells and viruses. Nat Rev Immunol. 2008 Apr; 8(4):259-68. PMID: 18340344; PMCID: PMC2584366.
    107. Long BR, Ndhlovu LC, Oksenberg JR, Lanier L, Hecht FM, Nixon DF, Barbour JD. Conferral of enhanced natural killer cell function by KIR3DS1 in early human immunodeficiency virus type 1 infection. J Virol. 2008 May; 82(10):4785-92. PMID: 18305035; PMCID: PMC2346752.
    108. Fang M, Lanier L, Sigal LJ. A role for NKG2D in NK cell-mediated resistance to poxvirus disease. PLoS Pathog. 2008 Feb 8; 4(2):e30. PMID: 18266471; PMCID: PMC2233669.
    109. Wang J, Shiratori I, Satoh T, Lanier L, Arase H. An essential role of sialylated O-linked sugar chains in the recognition of mouse CD99 by paired Ig-like type 2 receptor (PILR). J Immunol. 2008 Feb 1; 180(3):1686-93. PMID: 18209065; PMCID: PMC2577149.
    110. Chu CL, Yu YL, Shen KY, Lowell CA, Lanier L, Hamerman JA. Increased TLR responses in dendritic cells lacking the ITAM-containing adapters DAP12 and FcRgamma. Eur J Immunol. 2008 Jan; 38(1):166-73. PMID: 18081038; PMCID: PMC2587008.
    111. Michaëlsson J, Long BR, Loo CP, Lanier L, Spotts G, Hecht FM, Nixon DF. Immune reconstitution of CD56(dim) NK cells in individuals with primary HIV-1 infection treated with interleukin-2. J Infect Dis. 2008 Jan 1; 197(1):117-25. PMID: 18171294; PMCID: PMC4061976.
    112. Walsh KB, Lanier L, Lane TE. NKG2D receptor signaling enhances cytolytic activity by virus-specific CD8+ T cells: evidence for a protective role in virus-induced encephalitis. J Virol. 2008 Mar; 82(6):3031-44. PMID: 18160433; PMCID: PMC2259000.
    113. Walsh KB, Lodoen MB, Edwards RA, Lanier L, Lane TE. Evidence for differential roles for NKG2D receptor signaling in innate host defense against coronavirus-induced neurological and liver disease. J Virol. 2008 Mar; 82(6):3021-30. PMID: 18094157; PMCID: PMC2259007.
    114. Kim J, Chang CK, Hayden T, Liu FC, Benjamin J, Hamerman JA, Lanier L, Kang SM. The activating immunoreceptor NKG2D and its ligands are involved in allograft transplant rejection. J Immunol. 2007 Nov 15; 179(10):6416-20. PMID: 17982029.
      View in: PubMed
    115. Long BR, Michaelsson J, Loo CP, Ballan WM, Vu BA, Hecht FM, Lanier L, Chapman JM, Nixon DF. Elevated frequency of gamma interferon-producing NK cells in healthy adults vaccinated against influenza virus. Clin Vaccine Immunol. 2008 Jan; 15(1):120-30. PMID: 18003818; PMCID: PMC2223854.
    116. Vilarinho S, Ogasawara K, Nishimura S, Lanier L, Baron JL. Blockade of NKG2D on NKT cells prevents hepatitis and the acute immune response to hepatitis B virus. Proc Natl Acad Sci U S A. 2007 Nov 13; 104(46):18187-92. PMID: 17991774; PMCID: PMC2084318.
    117. Cao W, Zhang L, Rosen DB, Bover L, Watanabe G, Bao M, Lanier L, Liu YJ. BDCA2/Fc epsilon RI gamma complex signals through a novel BCR-like pathway in human plasmacytoid dendritic cells. PLoS Biol. 2007 Sep 11; 5(10):e248. PMID: 17850179; PMCID: PMC1971124.
    118. Ballan WM, Vu BA, Long BR, Loo CP, Michaëlsson J, Barbour JD, Lanier L, Wiznia AA, Abadi J, Fennelly GJ, Rosenberg MG, Nixon DF. Natural killer cells in perinatally HIV-1-infected children exhibit less degranulation compared to HIV-1-exposed uninfected children and their expression of KIR2DL3, NKG2C, and NKp46 correlates with disease severity. J Immunol. 2007 Sep 1; 179(5):3362-70. PMID: 17709553; PMCID: PMC4271645.
    119. Wu Y, Torchia J, Yao W, Lane NE, Lanier L, Nakamura MC, Humphrey MB. Bone microenvironment specific roles of ITAM adapter signaling during bone remodeling induced by acute estrogen-deficiency. PLoS One. 2007; 2(7):e586. PMID: 17611621; PMCID: PMC1895921.
    120. Lanier L. Back to the future--defining NK cells and T cells. Eur J Immunol. 2007 Jun; 37(6):1424-6. PMID: 17523211.
      View in: PubMed
    121. Adams EJ, Juo ZS, Venook RT, Boulanger MJ, Arase H, Lanier L, Garcia KC. Structural elucidation of the m157 mouse cytomegalovirus ligand for Ly49 natural killer cell receptors. Proc Natl Acad Sci U S A. 2007 Jun 12; 104(24):10128-33. PMID: 17537914; PMCID: PMC1891256.
    122. Carr WH, Rosen DB, Arase H, Nixon DF, Michaelsson J, Lanier L. Cutting Edge: KIR3DS1, a gene implicated in resistance to progression to AIDS, encodes a DAP12-associated receptor expressed on NK cells that triggers NK cell activation. J Immunol. 2007 Jan 15; 178(2):647-51. PMID: 17202323; PMCID: PMC2561215.
    123. Kielczewska A, Kim HS, Lanier L, Dimasi N, Vidal SM. Critical residues at the Ly49 natural killer receptor's homodimer interface determine functional recognition of m157, a mouse cytomegalovirus MHC class I-like protein. J Immunol. 2007 Jan 1; 178(1):369-77. PMID: 17182575.
      View in: PubMed
    124. Spits H, Lanier L. Natural killer or dendritic: what's in a name? Immunity. 2007 Jan; 26(1):11-6. PMID: 17241957.
      View in: PubMed
    125. Takaki R, Watson SR, Lanier L. DAP12: an adapter protein with dual functionality. Immunol Rev. 2006 Dec; 214:118-29. PMID: 17100880.
      View in: PubMed
    126. Berahovich RD, Lai NL, Wei Z, Lanier L, Schall TJ. Evidence for NK cell subsets based on chemokine receptor expression. J Immunol. 2006 Dec 1; 177(11):7833-40. PMID: 17114454.
      View in: PubMed
    127. Lanier L. Natural killer cells: roundup. Immunol Rev. 2006 Dec; 214:5-8. PMID: 17100871.
      View in: PubMed
    128. Mócsai A, Abram CL, Jakus Z, Hu Y, Lanier L, Lowell CA. Integrin signaling in neutrophils and macrophages uses adaptors containing immunoreceptor tyrosine-based activation motifs. Nat Immunol. 2006 Dec; 7(12):1326-33. PMID: 17086186.
      View in: PubMed
    129. Hamerman JA, Jarjoura JR, Humphrey MB, Nakamura MC, Seaman WE, Lanier L. Cutting edge: inhibition of TLR and FcR responses in macrophages by triggering receptor expressed on myeloid cells (TREM)-2 and DAP12. J Immunol. 2006 Aug 15; 177(4):2051-5. PMID: 16887962.
      View in: PubMed
    130. Lanier L. Viral immunoreceptor tyrosine-based activation motif (ITAM)-mediated signaling in cell transformation and cancer. Trends Cell Biol. 2006 Aug; 16(8):388-90. PMID: 16815013.
      View in: PubMed
    131. Lodoen MB, Lanier L. Natural killer cells as an initial defense against pathogens. Curr Opin Immunol. 2006 Aug; 18(4):391-8. PMID: 16765573.
      View in: PubMed
    132. Cao W, Rosen DB, Ito T, Bover L, Bao M, Watanabe G, Yao Z, Zhang L, Lanier L, Liu YJ. Plasmacytoid dendritic cell-specific receptor ILT7-Fc epsilonRI gamma inhibits Toll-like receptor-induced interferon production. J Exp Med. 2006 Jun 12; 203(6):1399-405. PMID: 16735691; PMCID: PMC2118323.
    133. Meresse B, Curran SA, Ciszewski C, Orbelyan G, Setty M, Bhagat G, Lee L, Tretiakova M, Semrad C, Kistner E, Winchester RJ, Braud V, Lanier L, Geraghty DE, Green PH, Guandalini S, Jabri B. Reprogramming of CTLs into natural killer-like cells in celiac disease. J Exp Med. 2006 May 15; 203(5):1343-55. PMID: 16682498; PMCID: PMC2121214.
    134. Hesslein DG, Takaki R, Hermiston ML, Weiss A, Lanier L. Dysregulation of signaling pathways in CD45-deficient NK cells leads to differentially regulated cytotoxicity and cytokine production. Proc Natl Acad Sci U S A. 2006 May 2; 103(18):7012-7. PMID: 16627620; PMCID: PMC1459010.
    135. Shiow LR, Rosen DB, Brdicková N, Xu Y, An J, Lanier L, Cyster JG, Matloubian M. CD69 acts downstream of interferon-alpha/beta to inhibit S1P1 and lymphocyte egress from lymphoid organs. Nature. 2006 Mar 23; 440(7083):540-4. PMID: 16525420.
      View in: PubMed
    136. Hamerman JA, Lanier L. Inhibition of immune responses by ITAM-bearing receptors. Sci STKE. 2006 Jan 31; 2006(320):re1. PMID: 16449667.
      View in: PubMed
    137. Chan CW, Crafton E, Fan HN, Flook J, Yoshimura K, Skarica M, Brockstedt D, Dubensky TW, Stins MF, Lanier L, Pardoll DM, Housseau F. Interferon-producing killer dendritic cells provide a link between innate and adaptive immunity. Nat Med. 2006 Feb; 12(2):207-13. PMID: 16444266.
      View in: PubMed
    138. Bui JD, Carayannopoulos LN, Lanier L, Yokoyama WM, Schreiber RD. IFN-dependent down-regulation of the NKG2D ligand H60 on tumors. J Immunol. 2006 Jan 15; 176(2):905-13. PMID: 16393975.
      View in: PubMed
    139. Vidal SM, Lanier L. NK cell recognition of mouse cytomegalovirus-infected cells. Curr Top Microbiol Immunol. 2006; 298:183-206. PMID: 16329187.
      View in: PubMed
    140. Walsh KB, Lodoen MB, Lanier L, Lane TE. NKG2D signaling and host defense after mouse hepatitis virus infection of the central nervous system. Adv Exp Med Biol. 2006; 581:369-72. PMID: 17037561.
      View in: PubMed
    141. Rosen DB, Bettadapura J, Alsharifi M, Mathew PA, Warren HS, Lanier L. Cutting edge: lectin-like transcript-1 is a ligand for the inhibitory human NKR-P1A receptor. J Immunol. 2005 Dec 15; 175(12):7796-9. PMID: 16339513.
      View in: PubMed
    142. Chen S, Kawashima H, Lowe JB, Lanier L, Fukuda M. Suppression of tumor formation in lymph nodes by L-selectin-mediated natural killer cell recruitment. J Exp Med. 2005 Dec 19; 202(12):1679-89. PMID: 16352740; PMCID: PMC2212958.
    143. Humphrey MB, Lanier L, Nakamura MC. Role of ITAM-containing adapter proteins and their receptors in the immune system and bone. Immunol Rev. 2005 Dec; 208:50-65. PMID: 16313340.
      View in: PubMed
    144. Routes JM, Ryan S, Morris K, Takaki R, Cerwenka A, Lanier L. Adenovirus serotype 5 E1A sensitizes tumor cells to NKG2D-dependent NK cell lysis and tumor rejection. J Exp Med. 2005 Dec 5; 202(11):1477-82. PMID: 16314433; PMCID: PMC2213342.
    145. Ogasawara K, Lanier L. NKG2D in NK and T cell-mediated immunity. J Clin Immunol. 2005 Nov; 25(6):534-40. PMID: 16380817.
      View in: PubMed
    146. Humphrey MB, Daws MR, Spusta SC, Niemi EC, Torchia JA, Lanier L, Seaman WE, Nakamura MC. TREM2, a DAP12-associated receptor, regulates osteoclast differentiation and function. J Bone Miner Res. 2006 Feb; 21(2):237-45. PMID: 16418779.
      View in: PubMed
    147. Shiratori I, Yamaguchi M, Suzukawa M, Yamamoto K, Lanier L, Saito T, Arase H. Down-regulation of basophil function by human CD200 and human herpesvirus-8 CD200. J Immunol. 2005 Oct 1; 175(7):4441-9. PMID: 16177086.
      View in: PubMed
    148. Takaki R, Hayakawa Y, Nelson A, Sivakumar PV, Hughes S, Smyth MJ, Lanier L. IL-21 enhances tumor rejection through a NKG2D-dependent mechanism. J Immunol. 2005 Aug 15; 175(4):2167-73. PMID: 16081783.
      View in: PubMed
    149. Ogasawara K, Benjamin J, Takaki R, Phillips JH, Lanier L. Function of NKG2D in natural killer cell-mediated rejection of mouse bone marrow grafts. Nat Immunol. 2005 Sep; 6(9):938-45. PMID: 16086018; PMCID: PMC1351289.
    150. Lanier L. Missing self, NK cells, and The White Album. J Immunol. 2005 Jun 1; 174(11):6565. PMID: 15905491.
      View in: PubMed
    151. Hamerman JA, Tchao NK, Lowell CA, Lanier L. Enhanced Toll-like receptor responses in the absence of signaling adaptor DAP12. Nat Immunol. 2005 Jun; 6(6):579-86. PMID: 15895090; PMCID: PMC1282462.
    152. Desrosiers MP, Kielczewska A, Loredo-Osti JC, Adam SG, Makrigiannis AP, Lemieux S, Pham T, Lodoen MB, Morgan K, Lanier L, Vidal SM. Epistasis between mouse Klra and major histocompatibility complex class I loci is associated with a new mechanism of natural killer cell-mediated innate resistance to cytomegalovirus infection. Nat Genet. 2005 Jun; 37(6):593-9. PMID: 15895081; PMCID: PMC1200556.
    153. Ehrlich LI, Ogasawara K, Hamerman JA, Takaki R, Zingoni A, Allison JP, Lanier L. Engagement of NKG2D by cognate ligand or antibody alone is insufficient to mediate costimulation of human and mouse CD8+ T cells. J Immunol. 2005 Feb 15; 174(4):1922-31. PMID: 15699119.
      View in: PubMed
    154. Hamerman JA, Ogasawara K, Lanier L. NK cells in innate immunity. Curr Opin Immunol. 2005 Feb; 17(1):29-35. PMID: 15653307.
      View in: PubMed
    155. Zingoni A, Sornasse T, Cocks BG, Tanaka Y, Santoni A, Lanier L. NK cell regulation of T cell-mediated responses. Mol Immunol. 2005 Feb; 42(4):451-4. PMID: 15607797.
      View in: PubMed
    156. Lanier L. First sighting of the elusive T cell antigen receptor. J Immunol. 2005 Feb 1; 174(3):1143. PMID: 15661865.
      View in: PubMed
    157. Lodoen MB, Lanier L. Viral modulation of NK cell immunity. Nat Rev Microbiol. 2005 Jan; 3(1):59-69. PMID: 15608700.
      View in: PubMed
    158. Lanier L. NKG2D in innate and adaptive immunity. Adv Exp Med Biol. 2005; 560:51-6. PMID: 15934171.
      View in: PubMed
    159. Lanier L. NK cell recognition. Annu Rev Immunol. 2005; 23:225-74. PMID: 15771571.
      View in: PubMed
    160. Bach JF, Bendelac A, Brenner MB, Cantor H, De Libero G, Kronenberg M, Lanier L, Raulet DH, Shlomchik MJ, von Herrath MG. The role of innate immunity in autoimmunity. J Exp Med. 2004 Dec 20; 200(12):1527-31. PMID: 15611284; PMCID: PMC2211986.
    161. Lodoen MB, Abenes G, Umamoto S, Houchins JP, Liu F, Lanier L. The cytomegalovirus m155 gene product subverts natural killer cell antiviral protection by disruption of H60-NKG2D interactions. J Exp Med. 2004 Oct 18; 200(8):1075-81. PMID: 15477345; PMCID: PMC2211837.
    162. Voehringer D, Rosen DB, Lanier L, Locksley RM. CD200 receptor family members represent novel DAP12-associated activating receptors on basophils and mast cells. J Biol Chem. 2004 Dec 24; 279(52):54117-23. PMID: 15471863.
      View in: PubMed
    163. Zingoni A, Sornasse T, Cocks BG, Tanaka Y, Santoni A, Lanier L. Cross-talk between activated human NK cells and CD4+ T cells via OX40-OX40 ligand interactions. J Immunol. 2004 Sep 15; 173(6):3716-24. PMID: 15356117.
      View in: PubMed
    164. Meresse B, Chen Z, Ciszewski C, Tretiakova M, Bhagat G, Krausz TN, Raulet DH, Lanier L, Groh V, Spies T, Ebert EC, Green PH, Jabri B. Coordinated induction by IL15 of a TCR-independent NKG2D signaling pathway converts CTL into lymphokine-activated killer cells in celiac disease. Immunity. 2004 Sep; 21(3):357-66. PMID: 15357947.
      View in: PubMed
    165. Rosen DB, Araki M, Hamerman JA, Chen T, Yamamura T, Lanier L. A Structural basis for the association of DAP12 with mouse, but not human, NKG2D. J Immunol. 2004 Aug 15; 173(4):2470-8. PMID: 15294961.
      View in: PubMed
    166. Ogasawara K, Hamerman JA, Ehrlich LR, Bour-Jordan H, Santamaria P, Bluestone JA, Lanier L. NKG2D blockade prevents autoimmune diabetes in NOD mice. Immunity. 2004 Jun; 20(6):757-67. PMID: 15189740.
      View in: PubMed
    167. Mócsai A, Humphrey MB, Van Ziffle JA, Hu Y, Burghardt A, Spusta SC, Majumdar S, Lanier L, Lowell CA, Nakamura MC. The immunomodulatory adapter proteins DAP12 and Fc receptor gamma-chain (FcRgamma) regulate development of functional osteoclasts through the Syk tyrosine kinase. Proc Natl Acad Sci U S A. 2004 Apr 20; 101(16):6158-63. PMID: 15073337; PMCID: PMC395939.
    168. Tahara-Hanaoka S, Shibuya K, Onoda Y, Zhang H, Yamazaki S, Miyamoto A, Honda S, Lanier L, Shibuya A. Functional characterization of DNAM-1 (CD226) interaction with its ligands PVR (CD155) and nectin-2 (PRR-2/CD112). Int Immunol. 2004 Apr; 16(4):533-8. PMID: 15039383.
      View in: PubMed
    169. Arase H, Lanier L. Specific recognition of virus-infected cells by paired NK receptors. Rev Med Virol. 2004 Mar-Apr; 14(2):83-93. PMID: 15027001.
      View in: PubMed
    170. Shiratori I, Ogasawara K, Saito T, Lanier L, Arase H. Activation of natural killer cells and dendritic cells upon recognition of a novel CD99-like ligand by paired immunoglobulin-like type 2 receptor. J Exp Med. 2004 Feb 16; 199(4):525-33. PMID: 14970179; PMCID: PMC2211832.
    171. Hamerman JA, Ogasawara K, Lanier L. Cutting edge: Toll-like receptor signaling in macrophages induces ligands for the NKG2D receptor. J Immunol. 2004 Feb 15; 172(4):2001-5. PMID: 14764662.
      View in: PubMed
    172. Humphrey MB, Ogasawara K, Yao W, Spusta SC, Daws MR, Lane NE, Lanier L, Nakamura MC. The signaling adapter protein DAP12 regulates multinucleation during osteoclast development. J Bone Miner Res. 2004 Feb; 19(2):224-34. PMID: 14969392.
      View in: PubMed
    173. Lanier L. NKG2D. J Biol Regul Homeost Agents. 2003 Oct-Dec; 17(4):338-40. PMID: 15065764.
      View in: PubMed
    174. Meyaard L, van der Vuurst de Vries AR, de Ruiter T, Lanier L, Phillips JH, Clevers H. Retraction. J Exp Med. 2003 Oct 6; 198(7):1129. PMID: 14517276; PMCID: PMC2194214.
    175. Westgaard IH, Dissen E, Torgersen KM, Lazetic S, Lanier L, Phillips JH, Fossum S. The lectin-like receptor KLRE1 inhibits natural killer cell cytotoxicity. J Exp Med. 2003 Jun 2; 197(11):1551-61. PMID: 12782717; PMCID: PMC2193914.
    176. Lanier L. Natural killer cell receptor signaling. Curr Opin Immunol. 2003 Jun; 15(3):308-14. PMID: 12787756.
      View in: PubMed
    177. Lodoen M, Ogasawara K, Hamerman JA, Arase H, Houchins JP, Mocarski ES, Lanier L. NKG2D-mediated natural killer cell protection against cytomegalovirus is impaired by viral gp40 modulation of retinoic acid early inducible 1 gene molecules. J Exp Med. 2003 May 19; 197(10):1245-53. PMID: 12756263; PMCID: PMC2193789.
    178. Zompi S, Hamerman JA, Ogasawara K, Schweighoffer E, Tybulewicz VL, Di Santo JP, Lanier L, Colucci F. NKG2D triggers cytotoxicity in mouse NK cells lacking DAP12 or Syk family kinases. Nat Immunol. 2003 Jun; 4(6):565-72. PMID: 12740576.
      View in: PubMed
    179. Cerwenka A, Lanier L. NKG2D ligands: unconventional MHC class I-like molecules exploited by viruses and cancer. Tissue Antigens. 2003 May; 61(5):335-43. PMID: 12753652.
      View in: PubMed
    180. Wu J, Lanier L. Natural killer cells and cancer. Adv Cancer Res. 2003; 90:127-56. PMID: 14710949.
      View in: PubMed
    181. Ogasawara K, Hamerman JA, Hsin H, Chikuma S, Bour-Jordan H, Chen T, Pertel T, Carnaud C, Bluestone JA, Lanier L. Impairment of NK cell function by NKG2D modulation in NOD mice. Immunity. 2003 Jan; 18(1):41-51. PMID: 12530974.
      View in: PubMed
    182. Cooper MD, Lanier L, Conley ME, Puck JM. Immunodeficiency disorders. Hematology Am Soc Hematol Educ Program. 2003; 314-30. PMID: 14633788.
      View in: PubMed
    183. Michaëlsson J, Teixeira de Matos C, Achour A, Lanier L, Kärre K, Söderström K. A signal peptide derived from hsp60 binds HLA-E and interferes with CD94/NKG2A recognition. J Exp Med. 2002 Dec 2; 196(11):1403-14. PMID: 12461076; PMCID: PMC2194258.
    184. Arase H, Lanier L. Virus-driven evolution of natural killer cell receptors. Microbes Infect. 2002 Dec; 4(15):1505-12. PMID: 12505522.
      View in: PubMed
    185. Ogasawara K, Yoshinaga SK, Lanier L. Inducible costimulator costimulates cytotoxic activity and IFN-gamma production in activated murine NK cells. J Immunol. 2002 Oct 1; 169(7):3676-85. PMID: 12244160.
      View in: PubMed
    186. Naper C, Hayashi S, Kveberg L, Niemi EC, Lanier L, Vaage JT, Ryan JC. Ly-49s3 is a promiscuous activating rat NK cell receptor for nonclassical MHC class I-encoded target ligands. J Immunol. 2002 Jul 1; 169(1):22-30. PMID: 12077224.
      View in: PubMed
    187. Arase H, Mocarski ES, Campbell AE, Hill AB, Lanier L. Direct recognition of cytomegalovirus by activating and inhibitory NK cell receptors. Science. 2002 May 17; 296(5571):1323-6. PMID: 11950999.
      View in: PubMed
    188. Cerwenka A, O'Callaghan CA, Hamerman JA, Yadav R, Ajayi W, Roopenian DC, Joyce S, Lanier L. Cutting edge: the minor histocompatibility antigen H60 peptide interacts with both H-2Kb and NKG2D. J Immunol. 2002 Apr 1; 168(7):3131-4. PMID: 11907062.
      View in: PubMed
    189. Masuda H, Saeki Y, Nomura M, Shida K, Matsumoto M, Ui M, Lanier L, Seya T. High levels of RAE-1 isoforms on mouse tumor cell lines assessed by anti-"pan" RAE-1 antibody confer tumor susceptibility to NK cells. Biochem Biophys Res Commun. 2002 Jan 11; 290(1):140-5. PMID: 11779145.
      View in: PubMed
    190. Lanier L. A renaissance for the tumor immunosurveillance hypothesis. Nat Med. 2001 Nov; 7(11):1178-80. PMID: 11689875.
      View in: PubMed
    191. Cerwenka A, Lanier L. Natural killer cells, viruses and cancer. Nat Rev Immunol. 2001 Oct; 1(1):41-9. PMID: 11905813.
      View in: PubMed
    192. Cerwenka A, Baron JL, Lanier L. Ectopic expression of retinoic acid early inducible-1 gene (RAE-1) permits natural killer cell-mediated rejection of a MHC class I-bearing tumor in vivo. Proc Natl Acad Sci U S A. 2001 Sep 25; 98(20):11521-6. PMID: 11562472; PMCID: PMC58762.
    193. Smith WL, Collins J, Lanier L, Rao VM. Initiative of the Council of Academic Societies. Redefining scholarship in academic radiology. Acad Radiol. 2001 Sep; 8(9):919-21. PMID: 11724049.
      View in: PubMed
    194. Arase H, Saito T, Phillips JH, Lanier L. Cutting edge: the mouse NK cell-associated antigen recognized by DX5 monoclonal antibody is CD49b (alpha 2 integrin, very late antigen-2). J Immunol. 2001 Aug 1; 167(3):1141-4. PMID: 11466327.
      View in: PubMed
    195. André P, Biassoni R, Colonna M, Cosman D, Lanier L, Long EO, Lopez-Botet M, Moretta A, Moretta L, Parham P, Trowsdale J, Vivier E, Wagtmann N, Wilson MJ. New nomenclature for MHC receptors. Nat Immunol. 2001 Aug; 2(8):661. PMID: 11477395.
      View in: PubMed
    196. Warren HS, Campbell AJ, Waldron JC, Lanier L. Biphasic response of NK cells expressing both activating and inhibitory killer Ig-like receptors. Int Immunol. 2001 Aug; 13(8):1043-52. PMID: 11470774.
      View in: PubMed
    197. O'Callaghan CA, Cerwenka A, Willcox BE, Lanier L, Bjorkman PJ. Molecular competition for NKG2D: H60 and RAE1 compete unequally for NKG2D with dominance of H60. Immunity. 2001 Aug; 15(2):201-11. PMID: 11520456.
      View in: PubMed
    198. Meyaard L, van der Vuurst de Vries AR, de Ruiter T, Lanier L, Phillips JH, Clevers H. The epithelial cellular adhesion molecule (Ep-CAM) is a ligand for the leukocyte-associated immunoglobulin-like receptor (LAIR). J Exp Med. 2001 Jul 2; 194(1):107-12. PMID: 11435477; PMCID: PMC2193444.
    199. Lanier L. Face off--the interplay between activating and inhibitory immune receptors. Curr Opin Immunol. 2001 Jun; 13(3):326-31. PMID: 11406364.
      View in: PubMed
    200. Cerwenka A, Lanier L. Ligands for natural killer cell receptors: redundancy or specificity. Immunol Rev. 2001 Jun; 181:158-69. PMID: 11513137.
      View in: PubMed
    201. Kadowaki N, Antonenko S, Ho S, Rissoan MC, Soumelis V, Porcelli SA, Lanier L, Liu YJ. Distinct cytokine profiles of neonatal natural killer T cells after expansion with subsets of dendritic cells. J Exp Med. 2001 May 21; 193(10):1221-6. PMID: 11369793; PMCID: PMC2193332.
    202. Steinle A, Li P, Morris DL, Groh V, Lanier L, Strong RK, Spies T. Interactions of human NKG2D with its ligands MICA, MICB, and homologs of the mouse RAE-1 protein family. Immunogenetics. 2001 May-Jun; 53(4):279-87. PMID: 11491531.
      View in: PubMed
    203. Yim D, Jie HB, Sotiriadis J, Kim YS, Kim KS, Rothschild MF, Lanier L, Kim YB. Molecular cloning and characterization of pig immunoreceptor DAP10 and NKG2D. Immunogenetics. 2001 Apr; 53(3):243-9. PMID: 11398969.
      View in: PubMed
    204. Young NT, Uhrberg M, Phillips JH, Lanier L, Parham P. Differential expression of leukocyte receptor complex-encoded Ig-like receptors correlates with the transition from effector to memory CTL. J Immunol. 2001 Mar 15; 166(6):3933-41. PMID: 11238638.
      View in: PubMed
    205. Uhrberg M, Valiante NM, Young NT, Lanier L, Phillips JH, Parham P. The repertoire of killer cell Ig-like receptor and CD94:NKG2A receptors in T cells: clones sharing identical alpha beta TCR rearrangement express highly diverse killer cell Ig-like receptor patterns. J Immunol. 2001 Mar 15; 166(6):3923-32. PMID: 11238637.
      View in: PubMed
    206. Daws MR, Lanier L, Seaman WE, Ryan JC. Cloning and characterization of a novel mouse myeloid DAP12-associated receptor family. Eur J Immunol. 2001 Mar; 31(3):783-91. PMID: 11241283.
      View in: PubMed
    207. Lanier L. On guard--activating NK cell receptors. Nat Immunol. 2001 Jan; 2(1):23-7. PMID: 11135574.
      View in: PubMed
    208. Lanier L, Bakker AB. The ITAM-bearing transmembrane adaptor DAP12 in lymphoid and myeloid cell function. Immunol Today. 2000 Dec; 21(12):611-4. PMID: 11114420.
      View in: PubMed
    209. Shibuya A, Sakamoto N, Shimizu Y, Shibuya K, Osawa M, Hiroyama T, Eyre HJ, Sutherland GR, Endo Y, Fujita T, Miyabayashi T, Sakano S, Tsuji T, Nakayama E, Phillips JH, Lanier L, Nakauchi H. Fc alpha/mu receptor mediates endocytosis of IgM-coated microbes. Nat Immunol. 2000 Nov; 1(5):441-6. PMID: 11062505.
      View in: PubMed
    210. Ravetch JV, Lanier L. Immune inhibitory receptors. Science. 2000 Oct 6; 290(5489):84-9. PMID: 11021804.
      View in: PubMed
    211. Wu J, Cherwinski H, Spies T, Phillips JH, Lanier L. DAP10 and DAP12 form distinct, but functionally cooperative, receptor complexes in natural killer cells. J Exp Med. 2000 Oct 2; 192(7):1059-68. PMID: 11015446; PMCID: PMC2193316.
    212. Tangye SG, Phillips JH, Lanier L, Nichols KE. Functional requirement for SAP in 2B4-mediated activation of human natural killer cells as revealed by the X-linked lymphoproliferative syndrome. J Immunol. 2000 Sep 15; 165(6):2932-6. PMID: 10975798.
      View in: PubMed
    213. Bakker AB, Hoek RM, Cerwenka A, Blom B, Lucian L, McNeil T, Murray R, Phillips LH, Sedgwick JD, Lanier L. DAP12-deficient mice fail to develop autoimmunity due to impaired antigen priming. Immunity. 2000 Sep; 13(3):345-53. PMID: 11021532.
      View in: PubMed
    214. Muench MO, Humeau L, Paek B, Ohkubo T, Lanier L, Albanese CT, Bárcena A. Differential effects of interleukin-3, interleukin-7, interleukin 15, and granulocyte-macrophage colony-stimulating factor in the generation of natural killer and B cells from primitive human fetal liver progenitors. Exp Hematol. 2000 Aug; 28(8):961-73. PMID: 10989197.
      View in: PubMed
    215. Paloneva J, Kestilä M, Wu J, Salminen A, Böhling T, Ruotsalainen V, Hakola P, Bakker AB, Phillips JH, Pekkarinen P, Lanier L, Timonen T, Peltonen L. Loss-of-function mutations in TYROBP (DAP12) result in a presenile dementia with bone cysts. Nat Genet. 2000 Jul; 25(3):357-61. PMID: 10888890.
      View in: PubMed
    216. Tangye SG, Cherwinski H, Lanier L, Phillips JH. 2B4-mediated activation of human natural killer cells. Mol Immunol. 2000 Jun; 37(9):493-501. PMID: 11163399.
      View in: PubMed
    217. Khakoo SI, Rajalingam R, Shum BP, Weidenbach K, Flodin L, Muir DG, Canavez F, Cooper SL, Valiante NM, Lanier L, Parham P. Rapid evolution of NK cell receptor systems demonstrated by comparison of chimpanzees and humans. Immunity. 2000 Jun; 12(6):687-98. PMID: 10894168.
      View in: PubMed
    218. Cerwenka A, Bakker AB, McClanahan T, Wagner J, Wu J, Phillips JH, Lanier L. Retinoic acid early inducible genes define a ligand family for the activating NKG2D receptor in mice. Immunity. 2000 Jun; 12(6):721-7. PMID: 10894171.
      View in: PubMed
    219. Yim D, Jie HB, Lanier L, Kim YB. Molecular cloning, gene structure, and expression pattern of pig immunoreceptor DAP12. Immunogenetics. 2000 May; 51(6):436-42. PMID: 10866110.
      View in: PubMed
    220. Lanier L. Turning on natural killer cells. J Exp Med. 2000 Apr 17; 191(8):1259-62. PMID: 10770793; PMCID: PMC2193135.
    221. Lanier L. The origin and functions of natural killer cells. Clin Immunol. 2000 Apr; 95(1 Pt 2):S14-8. PMID: 10729233.
      View in: PubMed
    222. Tangye SG, Phillips JH, Lanier L. The CD2-subset of the Ig superfamily of cell surface molecules: receptor-ligand pairs expressed by NK cells and other immune cells. Semin Immunol. 2000 Apr; 12(2):149-57. PMID: 10764623.
      View in: PubMed
    223. Pauza M, Smith KM, Neal H, Reilly C, Lanier L, Lo D. Transgenic expression of Ly-49A in thymocytes alters repertoire selection. J Immunol. 2000 Jan 15; 164(2):884-92. PMID: 10623836.
      View in: PubMed
    224. Chang C, Lanier L. Use of cDNA library expression cloning to identify components of heterodimeric receptor complexes. Methods Mol Biol. 2000; 121:273-81. PMID: 10818733.
      View in: PubMed
    225. Bakker AB, Wu J, Phillips JH, Lanier L. NK cell activation: distinct stimulatory pathways counterbalancing inhibitory signals. Hum Immunol. 2000 Jan; 61(1):18-27. PMID: 10658974.
      View in: PubMed
    226. Castro AG, Hauser TM, Cocks BG, Abrams J, Zurawski S, Churakova T, Zonin F, Robinson D, Tangye SG, Aversa G, Nichols KE, de Vries JE, Lanier L, O'Garra A. Molecular and functional characterization of mouse signaling lymphocytic activation molecule (SLAM): differential expression and responsiveness in Th1 and Th2 cells. J Immunol. 1999 Dec 1; 163(11):5860-70. PMID: 10570270.
      View in: PubMed
    227. Shibuya K, Lanier L, Phillips JH, Ochs HD, Shimizu K, Nakayama E, Nakauchi H, Shibuya A. Physical and functional association of LFA-1 with DNAM-1 adhesion molecule. Immunity. 1999 Nov; 11(5):615-23. PMID: 10591186.
      View in: PubMed
    228. Bakker AB, Baker E, Sutherland GR, Phillips JH, Lanier L. Myeloid DAP12-associating lectin (MDL)-1 is a cell surface receptor involved in the activation of myeloid cells. Proc Natl Acad Sci U S A. 1999 Aug 17; 96(17):9792-6. PMID: 10449773; PMCID: PMC22289.
    229. Bauer S, Groh V, Wu J, Steinle A, Phillips JH, Lanier L, Spies T. Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA. Science. 1999 Jul 30; 285(5428):727-9. PMID: 10426993.
      View in: PubMed
    230. Wu J, Song Y, Bakker AB, Bauer S, Spies T, Lanier L, Phillips JH. An activating immunoreceptor complex formed by NKG2D and DAP10. Science. 1999 Jul 30; 285(5428):730-2. PMID: 10426994.
      View in: PubMed
    231. Tangye SG, Lazetic S, Woollatt E, Sutherland GR, Lanier L, Phillips JH. Cutting edge: human 2B4, an activating NK cell receptor, recruits the protein tyrosine phosphatase SHP-2 and the adaptor signaling protein SAP. J Immunol. 1999 Jun 15; 162(12):6981-5. PMID: 10358138.
      View in: PubMed
    232. Meyaard L, Hurenkamp J, Clevers H, Lanier L, Phillips JH. Leukocyte-associated Ig-like receptor-1 functions as an inhibitory receptor on cytotoxic T cells. J Immunol. 1999 May 15; 162(10):5800-4. PMID: 10229813.
      View in: PubMed
    233. Lanier L. Natural killer cells fertile with receptors for HLA-G? Proc Natl Acad Sci U S A. 1999 May 11; 96(10):5343-5. PMID: 10318882; PMCID: PMC33573.
    234. Allan DS, Colonna M, Lanier L, Churakova TD, Abrams JS, Ellis SA, McMichael AJ, Braud VM. Tetrameric complexes of human histocompatibility leukocyte antigen (HLA)-G bind to peripheral blood myelomonocytic cells. J Exp Med. 1999 Apr 5; 189(7):1149-56. PMID: 10190906; PMCID: PMC2193000.
    235. Tangye SG, Wu J, Aversa G, de Vries JE, Lanier L, Phillips JH. Negative regulation of human T cell activation by the receptor-type protein tyrosine phosphatase CD148. J Immunol. 1998 Oct 15; 161(8):3803-7. PMID: 9780142.
      View in: PubMed
    236. Barton K, Muthusamy N, Fischer C, Ting CN, Walunas TL, Lanier L, Leiden JM. The Ets-1 transcription factor is required for the development of natural killer cells in mice. Immunity. 1998 Oct; 9(4):555-63. PMID: 9806641.
      View in: PubMed
    237. Tangye SG, Phillips JH, Lanier L, de Vries JE, Aversa G. CD148: a receptor-type protein tyrosine phosphatase involved in the regulation of human T cell activation. J Immunol. 1998 Oct 1; 161(7):3249-55. PMID: 9759839.
      View in: PubMed
    238. Shibuya A, Lanier L, Phillips JH. Protein kinase C is involved in the regulation of both signaling and adhesion mediated by DNAX accessory molecule-1 receptor. J Immunol. 1998 Aug 15; 161(4):1671-6. PMID: 9712030.
      View in: PubMed
    239. Smith KM, Wu J, Bakker AB, Phillips JH, Lanier L. Ly-49D and Ly-49H associate with mouse DAP12 and form activating receptors. J Immunol. 1998 Jul 1; 161(1):7-10. PMID: 9647200.
      View in: PubMed
    240. Bakker AB, Phillips JH, Figdor CG, Lanier L. Killer cell inhibitory receptors for MHC class I molecules regulate lysis of melanoma cells mediated by NK cells, gamma delta T cells, and antigen-specific CTL. J Immunol. 1998 Jun 1; 160(11):5239-45. PMID: 9605119.
      View in: PubMed
    241. Lanier L, Corliss B, Wu J, Phillips JH. Association of DAP12 with activating CD94/NKG2C NK cell receptors. Immunity. 1998 Jun; 8(6):693-701. PMID: 9655483.
      View in: PubMed
    242. Leong CC, Chapman TL, Bjorkman PJ, Formankova D, Mocarski ES, Phillips JH, Lanier L. Modulation of natural killer cell cytotoxicity in human cytomegalovirus infection: the role of endogenous class I major histocompatibility complex and a viral class I homolog. J Exp Med. 1998 May 18; 187(10):1681-7. PMID: 9584146; PMCID: PMC2212284.
    243. Lanier L. Follow the leader: NK cell receptors for classical and nonclassical MHC class I. Cell. 1998 Mar 20; 92(6):705-7. PMID: 9529246.
      View in: PubMed
    244. Braud VM, Allan DS, O'Callaghan CA, Söderström K, D'Andrea A, Ogg GS, Lazetic S, Young NT, Bell JI, Phillips JH, Lanier L, McMichael AJ. HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C. Nature. 1998 Feb 19; 391(6669):795-9. PMID: 9486650.
      View in: PubMed
    245. Lanier L, Corliss BC, Wu J, Leong C, Phillips JH. Immunoreceptor DAP12 bearing a tyrosine-based activation motif is involved in activating NK cells. Nature. 1998 Feb 12; 391(6668):703-7. PMID: 9490415.
      View in: PubMed
    246. Lanier L. Activating and inhibitory NK cell receptors. Adv Exp Med Biol. 1998; 452:13-8. PMID: 9889954.
      View in: PubMed
    247. D'Andrea A, Lanier L. Killer cell inhibitory receptor expression by T cells. Curr Top Microbiol Immunol. 1998; 230:25-39. PMID: 9586348.
      View in: PubMed
    248. Lanier L. NK cell receptors. Annu Rev Immunol. 1998; 16:359-93. PMID: 9597134.
      View in: PubMed
    249. Uhrberg M, Valiante NM, Shum BP, Shilling HG, Lienert-Weidenbach K, Corliss B, Tyan D, Lanier L, Parham P. Human diversity in killer cell inhibitory receptor genes. Immunity. 1997 Dec; 7(6):753-63. PMID: 9430221.
      View in: PubMed
    250. Valiante NM, Uhrberg M, Shilling HG, Lienert-Weidenbach K, Arnett KL, D'Andrea A, Phillips JH, Lanier L, Parham P. Functionally and structurally distinct NK cell receptor repertoires in the peripheral blood of two human donors. Immunity. 1997 Dec; 7(6):739-51. PMID: 9430220.
      View in: PubMed
    251. Söderström K, Corliss B, Lanier L, Phillips JH. CD94/NKG2 is the predominant inhibitory receptor involved in recognition of HLA-G by decidual and peripheral blood NK cells. J Immunol. 1997 Aug 1; 159(3):1072-5. PMID: 9233599.
      View in: PubMed
    252. Meyaard L, Adema GJ, Chang C, Woollatt E, Sutherland GR, Lanier L, Phillips JH. LAIR-1, a novel inhibitory receptor expressed on human mononuclear leukocytes. Immunity. 1997 Aug; 7(2):283-90. PMID: 9285412.
      View in: PubMed
    253. Jaleco AC, Blom B, Res P, Weijer K, Lanier L, Phillips JH, Spits H. Fetal liver contains committed NK progenitors, but is not a site for development of CD34+ cells into T cells. J Immunol. 1997 Jul 15; 159(2):694-702. PMID: 9218584.
      View in: PubMed
    254. Gumperz JE, Barber LD, Valiante NM, Percival L, Phillips JH, Lanier L, Parham P. Conserved and variable residues within the Bw4 motif of HLA-B make separable contributions to recognition by the NKB1 killer cell-inhibitory receptor. J Immunol. 1997 Jun 1; 158(11):5237-41. PMID: 9164941.
      View in: PubMed
    255. Houchins JP, Lanier L, Niemi EC, Phillips JH, Ryan JC. Natural killer cell cytolytic activity is inhibited by NKG2-A and activated by NKG2-C. J Immunol. 1997 Apr 15; 158(8):3603-9. PMID: 9103421.
      View in: PubMed
    256. Lanier L. Natural killer cells: from no receptors to too many. Immunity. 1997 Apr; 6(4):371-8. PMID: 9133416.
      View in: PubMed
    257. Lanier L. Natural killer cell receptors and MHC class I interactions. Curr Opin Immunol. 1997 Feb; 9(1):126-31. PMID: 9039769.
      View in: PubMed
    258. Lanier L, Corliss B, Phillips JH. Arousal and inhibition of human NK cells. Immunol Rev. 1997 Feb; 155:145-54. PMID: 9059890.
      View in: PubMed
    259. Renedo M, Arce I, Rodríguez A, Carretero M, Lanier L, López-Botet M, Fernández-Ruiz E. The human natural killer gene complex is located on chromosome 12p12-p13. Immunogenetics. 1997; 46(4):307-11. PMID: 9218532.
      View in: PubMed
    260. Binstadt BA, Brumbaugh KM, Dick CJ, Scharenberg AM, Williams BL, Colonna M, Lanier L, Kinet JP, Abraham RT, Leibson PJ. Sequential involvement of Lck and SHP-1 with MHC-recognizing receptors on NK cells inhibits FcR-initiated tyrosine kinase activation. Immunity. 1996 Dec; 5(6):629-38. PMID: 8986721.
      View in: PubMed
    261. Valiante NM, Phillips JH, Lanier L, Parham P. Killer cell inhibitory receptor recognition of human leukocyte antigen (HLA) class I blocks formation of a pp36/PLC-gamma signaling complex in human natural killer (NK) cells. J Exp Med. 1996 Dec 1; 184(6):2243-50. PMID: 8976179; PMCID: PMC2196393.
    262. Lazetic S, Chang C, Houchins JP, Lanier L, Phillips JH. Human natural killer cell receptors involved in MHC class I recognition are disulfide-linked heterodimers of CD94 and NKG2 subunits. J Immunol. 1996 Dec 1; 157(11):4741-5. PMID: 8943374.
      View in: PubMed
    263. Gumperz JE, Paterson JC, Litwin V, Valiante N, Lanier L, Parham P, Little AM. Specificity of two anti-class I HLA monoclonal antibodies that block class I recognition by the NKB1 killer cell inhibitory receptor. Tissue Antigens. 1996 Oct; 48(4 Pt 1):278-84. PMID: 8946681.
      View in: PubMed
    264. D'Andrea A, Chang C, Phillips JH, Lanier L. Regulation of T cell lymphokine production by killer cell inhibitory receptor recognition of self HLA class I alleles. J Exp Med. 1996 Aug 1; 184(2):789-94. PMID: 8760835; PMCID: PMC2192731.
    265. Phillips JH, Chang C, Mattson J, Gumperz JE, Parham P, Lanier L. CD94 and a novel associated protein (94AP) form a NK cell receptor involved in the recognition of HLA-A, HLA-B, and HLA-C allotypes. Immunity. 1996 Aug; 5(2):163-72. PMID: 8769479.
      View in: PubMed
    266. Barber LD, Percival L, Valiante NM, Chen L, Lee C, Gumperz JE, Phillips JH, Lanier L, Bigge JC, Parekh RB, Parham P. The inter-locus recombinant HLA-B*4601 has high selectivity in peptide binding and functions characteristic of HLA-C. J Exp Med. 1996 Aug 1; 184(2):735-40. PMID: 8760827; PMCID: PMC2192697.
    267. Fry AM, Lanier L, Weiss A. Phosphotyrosines in the killer cell inhibitory receptor motif of NKB1 are required for negative signaling and for association with protein tyrosine phosphatase 1C. J Exp Med. 1996 Jul 1; 184(1):295-300. PMID: 8691146; PMCID: PMC2192670.
    268. Shibuya A, Campbell D, Hannum C, Yssel H, Franz-Bacon K, McClanahan T, Kitamura T, Nicholl J, Sutherland GR, Lanier L, Phillips JH. DNAM-1, a novel adhesion molecule involved in the cytolytic function of T lymphocytes. Immunity. 1996 Jun; 4(6):573-81. PMID: 8673704.
      View in: PubMed
    269. Warren HS, Kinnear BF, Kastelein RL, Lanier L. Analysis of the costimulatory role of IL-2 and IL-15 in initiating proliferation of resting (CD56dim) human NK cells. J Immunol. 1996 May 1; 156(9):3254-9. PMID: 8617947.
      View in: PubMed
    270. Barber LD, Patel TP, Percival L, Gumperz JE, Lanier L, Phillips JH, Bigge JC, Wormwald MR, Parekh RB, Parham P. Unusual uniformity of the N-linked oligosaccharides of HLA-A, -B, and -C glycoproteins. J Immunol. 1996 May 1; 156(9):3275-84. PMID: 8617950.
      View in: PubMed
    271. Gumperz JE, Valiante NM, Parham P, Lanier L, Tyan D. Heterogeneous phenotypes of expression of the NKB1 natural killer cell class I receptor among individuals of different human histocompatibility leukocyte antigens types appear genetically regulated, but not linked to major histocompatibililty complex haplotype. J Exp Med. 1996 Apr 1; 183(4):1817-27. PMID: 8666938; PMCID: PMC2192483.
    272. Onishi M, Kinoshita S, Morikawa Y, Shibuya A, Phillips J, Lanier L, Gorman DM, Nolan GP, Miyajima A, Kitamura T. Applications of retrovirus-mediated expression cloning. Exp Hematol. 1996 Feb; 24(2):324-9. PMID: 8641361.
      View in: PubMed
    273. Long EO, Colonna M, Lanier L. Inhibitory MHC class I receptors on NK and T cells: a standard nomenclature. Immunol Today. 1996 Feb; 17(2):100. PMID: 8808061.
      View in: PubMed
    274. Lanier L, Phillips JH. Inhibitory MHC class I receptors on NK cells and T cells. Immunol Today. 1996 Feb; 17(2):86-91. PMID: 8808056.
      View in: PubMed
    275. D'Andrea A, Lanier L. NKB1: a killer cell inhibitory receptor for class I HLA-B allotypes. Chem Immunol. 1996; 64:104-15. PMID: 8942075.
      View in: PubMed
    276. Lanier L. The role of natural killer cells in transplantation. Curr Opin Immunol. 1995 Oct; 7(5):626-31. PMID: 8573304.
      View in: PubMed
    277. D'Andrea A, Chang C, Franz-Bacon K, McClanahan T, Phillips JH, Lanier L. Molecular cloning of NKB1. A natural killer cell receptor for HLA-B allotypes. J Immunol. 1995 Sep 1; 155(5):2306-10. PMID: 7650366.
      View in: PubMed
    278. Chang C, Rodríguez A, Carretero M, López-Botet M, Phillips JH, Lanier L. Molecular characterization of human CD94: a type II membrane glycoprotein related to the C-type lectin superfamily. Eur J Immunol. 1995 Sep; 25(9):2433-7. PMID: 7589107.
      View in: PubMed
    279. Spits H, Lanier L, Phillips JH. Development of human T and natural killer cells. Blood. 1995 May 15; 85(10):2654-70. PMID: 7742523.
      View in: PubMed
    280. Warren HS, Kinnear BF, Phillips JH, Lanier L. Production of IL-5 by human NK cells and regulation of IL-5 secretion by IL-4, IL-10, and IL-12. J Immunol. 1995 May 15; 154(10):5144-52. PMID: 7730620.
      View in: PubMed
    281. Fernández-Ruiz E, Somoza C, Sánchez-Madrid F, Lanier L. CD28/CTLA-4 ligands: the gene encoding CD86 (B70/B7.2) maps to the same region as CD80 (B7/B7.1) gene in human chromosome 3q13-q23. Eur J Immunol. 1995 May; 25(5):1453-6. PMID: 7539761.
      View in: PubMed
    282. Phillips JH, Gumperz JE, Parham P, Lanier L. Superantigen-dependent, cell-mediated cytotoxicity inhibited by MHC class I receptors on T lymphocytes. Science. 1995 Apr 21; 268(5209):403-5. PMID: 7716542.
      View in: PubMed
    283. Lanier L, Gumperz JE, Parham P, Melero I, López-Botet M, Phillips JH. The NKB1 and HP-3E4 NK cells receptors are structurally distinct glycoproteins and independently recognize polymorphic HLA-B and HLA-C molecules. J Immunol. 1995 Apr 1; 154(7):3320-7. PMID: 7897214.
      View in: PubMed
    284. Lanier L, Phillips JH. NK cell recognition of major histocompatibility complex class I molecules. Semin Immunol. 1995 Apr; 7(2):75-82. PMID: 7579197.
      View in: PubMed
    285. Somoza C, Lanier L. T-cell costimulation via CD28-CD80/CD86 and CD40-CD40 ligand interactions. Res Immunol. 1995 Mar-Apr; 146(3):171-6. PMID: 8525049.
      View in: PubMed
    286. Gumperz JE, Litwin V, Phillips JH, Lanier L, Parham P. The Bw4 public epitope of HLA-B molecules confers reactivity with natural killer cell clones that express NKB1, a putative HLA receptor. J Exp Med. 1995 Mar 1; 181(3):1133-44. PMID: 7532677; PMCID: PMC2191933.
    287. Lanier L, O'Fallon S, Somoza C, Phillips JH, Linsley PS, Okumura K, Ito D, Azuma M. CD80 (B7) and CD86 (B70) provide similar costimulatory signals for T cell proliferation, cytokine production, and generation of CTL. J Immunol. 1995 Jan 1; 154(1):97-105. PMID: 7527824.
      View in: PubMed
    288. Azuma M, Lanier L. The role of CD28 costimulation in the generation of cytotoxic T lymphocytes. Curr Top Microbiol Immunol. 1995; 198:59-74. PMID: 7774283.
      View in: PubMed
    289. Caux C, Vanbervliet B, Massacrier C, Azuma M, Okumura K, Lanier L, Banchereau J. B70/B7-2 is identical to CD86 and is the major functional ligand for CD28 expressed on human dendritic cells. J Exp Med. 1994 Nov 1; 180(5):1841-7. PMID: 7525840; PMCID: PMC2191743.
    290. Cifone MG, De Maria R, Roncaioli P, Rippo MR, Azuma M, Lanier L, Santoni A, Testi R. Apoptotic signaling through CD95 (Fas/Apo-1) activates an acidic sphingomyelinase. J Exp Med. 1994 Oct 1; 180(4):1547-52. PMID: 7523573; PMCID: PMC2191710.
    291. Lanier L, Chang C, Phillips JH. Human NKR-P1A. A disulfide-linked homodimer of the C-type lectin superfamily expressed by a subset of NK and T lymphocytes. J Immunol. 1994 Sep 15; 153(6):2417-28. PMID: 8077657.
      View in: PubMed
    292. Sánchez MJ, Muench MO, Roncarolo MG, Lanier L, Phillips JH. Identification of a common T/natural killer cell progenitor in human fetal thymus. J Exp Med. 1994 Aug 1; 180(2):569-76. PMID: 7519241; PMCID: PMC2191594.
    293. Litwin V, Gumperz J, Parham P, Phillips JH, Lanier L. NKB1: a natural killer cell receptor involved in the recognition of polymorphic HLA-B molecules. J Exp Med. 1994 Aug 1; 180(2):537-43. PMID: 8046332; PMCID: PMC2191610.
    294. Murphy EE, Terres G, Macatonia SE, Hsieh CS, Mattson J, Lanier L, Wysocka M, Trinchieri G, Murphy K, O'Garra A. B7 and interleukin 12 cooperate for proliferation and interferon gamma production by mouse T helper clones that are unresponsive to B7 costimulation. J Exp Med. 1994 Jul 1; 180(1):223-31. PMID: 7516409; PMCID: PMC2191551.
    295. Cayabyab M, Phillips JH, Lanier L. CD40 preferentially costimulates activation of CD4+ T lymphocytes. J Immunol. 1994 Feb 15; 152(4):1523-31. PMID: 7509825.
      View in: PubMed
    296. Sánchez MJ, Spits H, Lanier L, Phillips JH. Human natural killer cell committed thymocytes and their relation to the T cell lineage. J Exp Med. 1993 Dec 1; 178(6):1857-66. PMID: 7504051; PMCID: PMC2191276.
    297. Azuma M, Ito D, Yagita H, Okumura K, Phillips JH, Lanier L, Somoza C. B70 antigen is a second ligand for CTLA-4 and CD28. Nature. 1993 Nov 4; 366(6450):76-9. PMID: 7694153.
      View in: PubMed
    298. Litwin V, Gumperz J, Parham P, Phillips JH, Lanier L. Specificity of HLA class I antigen recognition by human NK clones: evidence for clonal heterogeneity, protection by self and non-self alleles, and influence of the target cell type. J Exp Med. 1993 Oct 1; 178(4):1321-36. PMID: 8376937; PMCID: PMC2191205.
    299. Yssel H, Schneider PV, Lanier L. Interleukin-7 specifically induces the B7/BB1 antigen on human cord blood and peripheral blood T cells and T cell clones. Int Immunol. 1993 Jul; 5(7):753-9. PMID: 7690242.
      View in: PubMed
    300. Lanier L. Distribution and function of lymphocyte surface antigens. Molecules costimulating T lymphocyte activation and effector function. Ann N Y Acad Sci. 1993 Mar 20; 677:86-93. PMID: 8494250.
      View in: PubMed
    301. Azuma M, Cayabyab M, Phillips JH, Lanier L. Requirements for CD28-dependent T cell-mediated cytotoxicity. J Immunol. 1993 Mar 15; 150(6):2091-101. PMID: 8383716.
      View in: PubMed
    302. Azuma M, Yssel H, Phillips JH, Spits H, Lanier L. Functional expression of B7/BB1 on activated T lymphocytes. J Exp Med. 1993 Mar 1; 177(3):845-50. PMID: 7679711; PMCID: PMC2190946.
    303. Azuma M, Phillips JH, Lanier L. CD28- T lymphocytes. Antigenic and functional properties. J Immunol. 1993 Feb 15; 150(4):1147-59. PMID: 8381831.
      View in: PubMed
    304. Lanier L, Spits H, Phillips JH. The developmental relationship between NK cells and T cells. Immunol Today. 1992 Oct; 13(10):392-5. PMID: 1418374.
      View in: PubMed
    305. Lanier L, Chang C, Spits H, Phillips JH. Expression of cytoplasmic CD3 epsilon proteins in activated human adult natural killer (NK) cells and CD3 gamma, delta, epsilon complexes in fetal NK cells. Implications for the relationship of NK and T lymphocytes. J Immunol. 1992 Sep 15; 149(6):1876-80. PMID: 1387664.
      View in: PubMed
    306. Hori T, Phillips JH, Duncan B, Lanier L, Spits H. Human fetal liver-derived CD7+CD2lowCD3-CD56- clones that express CD3 gamma, delta, and epsilon and proliferate in response to interleukin-2 (IL-2), IL-3, IL-4, or IL-7: implications for the relationship between T and natural killer cells. Blood. 1992 Sep 1; 80(5):1270-8. PMID: 1381242.
      View in: PubMed
    307. Azuma M, Cayabyab M, Buck D, Phillips JH, Lanier L. Involvement of CD28 in MHC-unrestricted cytotoxicity mediated by a human natural killer leukemia cell line. J Immunol. 1992 Aug 15; 149(4):1115-23. PMID: 1380031.
      View in: PubMed
    308. Phillips JH, Hori T, Nagler A, Bhat N, Spits H, Lanier L. Ontogeny of human natural killer (NK) cells: fetal NK cells mediate cytolytic function and express cytoplasmic CD3 epsilon,delta proteins. J Exp Med. 1992 Apr 1; 175(4):1055-66. PMID: 1372642; PMCID: PMC2119193.
    309. Lanier L, Phillips JH. Natural killer cells. Curr Opin Immunol. 1992 Feb; 4(1):38-42. PMID: 1596367.
      View in: PubMed
    310. Azuma M, Cayabyab M, Buck D, Phillips JH, Lanier L. CD28 interaction with B7 costimulates primary allogeneic proliferative responses and cytotoxicity mediated by small, resting T lymphocytes. J Exp Med. 1992 Feb 1; 175(2):353-60. PMID: 1370679; PMCID: PMC2119127.
    311. Azuma M, Phillips JH, Lanier L. CD28 co-stimulation of T-cell-mediated cytotoxicity. Int J Cancer Suppl. 1992; 7:33-5. PMID: 1330948.
      View in: PubMed
    312. Phillips JH, McKinney L, Azuma M, Spits H, Lanier L. A novel beta 4, alpha 6 integrin-associated epithelial cell antigen involved in natural killer cell and antigen-specific cytotoxic T lymphocyte cytotoxicity. J Exp Med. 1991 Dec 1; 174(6):1571-81. PMID: 1744585; PMCID: PMC2119019.
    313. Harrison D, Phillips JH, Lanier L. Involvement of a metalloprotease in spontaneous and phorbol ester-induced release of natural killer cell-associated Fc gamma RIII (CD16-II). J Immunol. 1991 Nov 15; 147(10):3459-65. PMID: 1834741.
      View in: PubMed
    314. Lanier L, Chang C, Azuma M, Ruitenberg JJ, Hemperly JJ, Phillips JH. Molecular and functional analysis of human natural killer cell-associated neural cell adhesion molecule (N-CAM/CD56). J Immunol. 1991 Jun 15; 146(12):4421-6. PMID: 1710251.
      View in: PubMed
    315. Phillips JH, Chang CW, Lanier L. Platelet-induced expression of Fc gamma RIII (CD16) on human monocytes. Eur J Immunol. 1991 Apr; 21(4):895-9. PMID: 1826887.
      View in: PubMed
    316. Lanier L, Yu G, Phillips JH. Analysis of Fc gamma RIII (CD16) membrane expression and association with CD3 zeta and Fc epsilon RI-gamma by site-directed mutation. J Immunol. 1991 Mar 1; 146(5):1571-6. PMID: 1825220.
      View in: PubMed
    317. Nagler A, Lanier L, Phillips JH. Constitutive expression of high affinity interleukin 2 receptors on human CD16-natural killer cells in vivo. J Exp Med. 1990 May 1; 171(5):1527-33. PMID: 2139697; PMCID: PMC2187903.
    318. Lanier L, Cwirla S, Yu G, Testi R, Phillips JH. Membrane anchoring of a human IgG Fc receptor (CD16) determined by a single amino acid. Science. 1989 Dec 22; 246(4937):1611-3. PMID: 2531919.
      View in: PubMed
    319. Lanier L, Yu G, Phillips JH. Co-association of CD3 zeta with a receptor (CD16) for IgG Fc on human natural killer cells. Nature. 1989 Dec 14; 342(6251):803-5. PMID: 2532305.
      View in: PubMed
    320. Nagler A, Lanier L, Cwirla S, Phillips JH. Comparative studies of human FcRIII-positive and negative natural killer cells. J Immunol. 1989 Nov 15; 143(10):3183-91. PMID: 2530273.
      View in: PubMed
    321. Testi R, Phillips JH, Lanier L. T cell activation via Leu-23 (CD69). J Immunol. 1989 Aug 15; 143(4):1123-8. PMID: 2501389.
      View in: PubMed
    322. Clark EA, Lanier L. Report from Vienna: in search of all surface molecules expressed on human leukocytes. J Clin Immunol. 1989 Jul; 9(4):265-72. PMID: 2788657.
      View in: PubMed
    323. Phillips JH, Takeshita T, Sugamura K, Lanier L. Activation of natural killer cells via the p75 interleukin 2 receptor. J Exp Med. 1989 Jul 1; 170(1):291-6. PMID: 2787381; PMCID: PMC2189366.
    324. Lanier L, Testi R, Bindl J, Phillips JH. Identity of Leu-19 (CD56) leukocyte differentiation antigen and neural cell adhesion molecule. J Exp Med. 1989 Jun 1; 169(6):2233-8. PMID: 2471777; PMCID: PMC2189344.
    325. Groh V, Porcelli S, Fabbi M, Lanier L, Picker LJ, Anderson T, Warnke RA, Bhan AK, Strominger JL, Brenner MB. Human lymphocytes bearing T cell receptor gamma/delta are phenotypically diverse and evenly distributed throughout the lymphoid system. J Exp Med. 1989 Apr 1; 169(4):1277-94. PMID: 2564416; PMCID: PMC2189233.
    326. Lanier L, Phillips JH, Testi R. Membrane anchoring and spontaneous release of CD16 (FcR III) by natural killer cells and granulocytes. Eur J Immunol. 1989 Apr; 19(4):775-8. PMID: 2525100.
      View in: PubMed
    327. Testi R, Phillips JH, Lanier L. Leu 23 induction as an early marker of functional CD3/T cell antigen receptor triggering. Requirement for receptor cross-linking, prolonged elevation of intracellular [Ca++] and stimulation of protein kinase C. J Immunol. 1989 Mar 15; 142(6):1854-60. PMID: 2466079.
      View in: PubMed
    328. Loh EY, Elliott JF, Cwirla S, Lanier L, Davis MM. Polymerase chain reaction with single-sided specificity: analysis of T cell receptor delta chain. Science. 1989 Jan 13; 243(4888):217-20. PMID: 2463672.
      View in: PubMed
    329. Testi R, Lanier L. Functional expression of CD28 on T cell antigen receptor gamma/delta-bearing T lymphocytes. Eur J Immunol. 1989 Jan; 19(1):185-8. PMID: 2537735.
      View in: PubMed
    330. Loh EY, Cwirla S, Serafini AT, Phillips JH, Lanier L. Human T-cell-receptor delta chain: genomic organization, diversity, and expression in populations of cells. Proc Natl Acad Sci U S A. 1988 Dec; 85(24):9714-8. PMID: 2974163; PMCID: PMC282846.
    331. Lanier L, Ruitenberg J, Bolhuis RL, Borst J, Phillips JH, Testi R. Structural and serological heterogeneity of gamma/delta T cell antigen receptor expression in thymus and peripheral blood. Eur J Immunol. 1988 Dec; 18(12):1985-92. PMID: 2975598.
      View in: PubMed
    332. Lanier L, Ruitenberg JJ, Phillips JH. Functional and biochemical analysis of CD16 antigen on natural killer cells and granulocytes. J Immunol. 1988 Nov 15; 141(10):3478-85. PMID: 2903193.
      View in: PubMed
    333. Arnaout MA, Lanier L, Faller DV. Relative contribution of the leukocyte molecules Mo1, LFA-1, and p150,95 (LeuM5) in adhesion of granulocytes and monocytes to vascular endothelium is tissue- and stimulus-specific. J Cell Physiol. 1988 Nov; 137(2):305-9. PMID: 3056960.
      View in: PubMed
    334. Testi R, Phillips JH, Lanier L. Constitutive expression of a phosphorylated activation antigen (Leu 23) by CD3bright human thymocytes. J Immunol. 1988 Oct 15; 141(8):2557-63. PMID: 3262663.
      View in: PubMed
    335. Nagler A, Lanier L, Phillips JH. The effects of IL-4 on human natural killer cells. A potent regulator of IL-2 activation and proliferation. J Immunol. 1988 Oct 1; 141(7):2349-51. PMID: 3262658.
      View in: PubMed
    336. Lanier L, Phillips JH. Effectors, repertoire and receptors involved in lymphocyte-mediated mhc-unrestricted cytotoxicity. Ann Inst Pasteur Immunol. 1988 Jul-Aug; 139(4):450-6. PMID: 3262356.
      View in: PubMed
    337. Nagler A, Greenberg PL, Lanier L, Phillips JH. The effects of recombinant interleukin 2-activated natural killer cells on autologous peripheral blood hematopoietic progenitors. J Exp Med. 1988 Jul 1; 168(1):47-54. PMID: 3260939; PMCID: PMC2188970.
    338. Lanier L, Buck DW, Rhodes L, Ding A, Evans E, Barney C, Phillips JH. Interleukin 2 activation of natural killer cells rapidly induces the expression and phosphorylation of the Leu-23 activation antigen. J Exp Med. 1988 May 1; 167(5):1572-85. PMID: 3259252; PMCID: PMC2188935.
    339. Skettino S, Phillips J, Lanier L, Nagler A, Greenberg P. Selective generation of erythroid burst-promoting activity by recombinant interleukin 2-stimulated human T lymphocytes and natural killer cells. Blood. 1988 Apr; 71(4):907-14. PMID: 2833331.
      View in: PubMed
    340. Richie ER, McEntire B, Crispe N, Kimura J, Lanier L, Allison JP. Alpha/beta T-cell antigen receptor gene and protein expression occurs at early stages of thymocyte differentiation. Proc Natl Acad Sci U S A. 1988 Feb; 85(4):1174-8. PMID: 2963339; PMCID: PMC279729.
    341. Loh EY, Lanier L, Turck CW, Littman DR, Davis MM, Chien YH, Weiss A. Identification and sequence of a fourth human T cell antigen receptor chain. Nature. 1987 Dec 10-16; 330(6148):569-72. PMID: 2825032.
      View in: PubMed
    342. Phillips JH, Gemlo BT, Myers WW, Rayner AA, Lanier L. In vivo and in vitro activation of natural killer cells in advanced cancer patients undergoing combined recombinant interleukin-2 and LAK cell therapy. J Clin Oncol. 1987 Dec; 5(12):1933-41. PMID: 3500280.
      View in: PubMed
    343. Weiss A, Dazin PF, Shields R, Fu SM, Lanier L. Functional competency of T cell antigen receptors in human thymus. J Immunol. 1987 Nov 15; 139(10):3245-50. PMID: 3500209.
      View in: PubMed
    344. Phillips JH, Weiss A, Gemlo BT, Rayner AA, Lanier L. Evidence that the T cell antigen receptor may not be involved in cytotoxicity mediated by gamma/delta and alpha/beta thymic cell lines. J Exp Med. 1987 Nov 1; 166(5):1579-84. PMID: 3500263; PMCID: PMC2189654.
    345. Lanier L, Serafini AT, Ruitenberg JJ, Cwirla S, Federspiel NA, Phillips JH, Allison JP, Weiss A. The gamma T-cell antigen receptor. J Clin Immunol. 1987 Nov; 7(6):429-40. PMID: 3320076.
      View in: PubMed
    346. Phillips JH, Lanier L. Acquisition of non-MHC restricted cytotoxic function by IL 2 activated thymocytes with an "immature" antigenic phenotype. J Immunol. 1987 Aug 1; 139(3):683-7. PMID: 3110279.
      View in: PubMed
    347. Lanier L, Le AM, Ding A, Evans EL, Krensky AM, Clayberger C, Phillips JH. Expression of Leu-19 (NKH-1) antigen on IL 2-dependent cytotoxic and non-cytotoxic T cell lines. J Immunol. 1987 Apr 1; 138(7):2019-23. PMID: 2951430.
      View in: PubMed
    348. Lanier L, Federspiel NA, Ruitenberg JJ, Phillips JH, Allison JP, Littman D, Weiss A. The T cell antigen receptor complex expressed on normal peripheral blood CD4-, CD8- T lymphocytes. A CD3-associated disulfide-linked gamma chain heterodimer. J Exp Med. 1987 Apr 1; 165(4):1076-94. PMID: 2435832; PMCID: PMC2188591.
    349. Freimark B, Lanier L, Phillips J, Quertermous T, Fox R. Comparison of T cell receptor gene rearrangements in patients with large granular T cell leukemia and Felty's syndrome. J Immunol. 1987 Mar 15; 138(6):1724-9. PMID: 3102595.
      View in: PubMed
    350. Nagasawa R, Gross J, Kanagawa O, Townsend K, Lanier L, Chiller J, Allison JP. Identification of a novel T cell surface disulfide-bonded dimer distinct from the alpha/beta antigen receptor. J Immunol. 1987 Feb 1; 138(3):815-24. PMID: 2433330.
      View in: PubMed
    351. Allison JP, Lanier L. Structure, function, and serology of the T-cell antigen receptor complex. Annu Rev Immunol. 1987; 5:503-40. PMID: 2439105.
      View in: PubMed
    352. Allison JP, Lanier L. The T-cell antigen receptor gamma gene: rearrangement and cell lineages. Immunol Today. 1987; 8(10):293-6. PMID: 25290833.
      View in: PubMed
    353. Herberman RB, Hiserodt J, Vujanovic N, Balch C, Lotzova E, Bolhuis R, Golub S, Lanier L, Phillips JH, Riccardi C, Ritz J, Santoni A, Schmidt RE, Uchida A. Lymphokine-activated killer cell activity Characteristics of effector cells and their progenitors in blood and spleen. Immunol Today. 1987; 8(6):178-81. PMID: 25290217.
      View in: PubMed
    354. Lanier L, Cwirla S, Phillips JH. Genomic organization of T cell gamma genes in human peripheral blood natural killer cells. J Immunol. 1986 Dec 1; 137(11):3375-7. PMID: 3491133.
      View in: PubMed
    355. Lanier L, Le AM, Cwirla S, Federspiel N, Phillips JH. Antigenic, functional, and molecular genetic studies of human natural killer cells and cytotoxic T lymphocytes not restricted by the major histocompatibility complex. Fed Proc. 1986 Nov; 45(12):2823-8. PMID: 3095151.
      View in: PubMed
    356. Lanier L, Weiss A. Presence of Ti (WT31) negative T lymphocytes in normal blood and thymus. Nature. 1986 Nov 20-26; 324(6094):268-70. PMID: 3491323.
      View in: PubMed
    357. Lanier L, Phillips JH, Hackett J, Tutt M, Kumar V. Natural killer cells: definition of a cell type rather than a function. J Immunol. 1986 Nov 1; 137(9):2735-9. PMID: 3489775.
      View in: PubMed
    358. Lanier L, Allison JP, Phillips JH. Correlation of cell surface antigen expression on human thymocytes by multi-color flow cytometric analysis: implications for differentiation. J Immunol. 1986 Oct 15; 137(8):2501-7. PMID: 3531334.
      View in: PubMed
    359. Tarkkanen J, Saksela E, Lanier L. Bacterial activation of human natural killer cells. Characteristics of the activation process and identification of the effector cell. J Immunol. 1986 Oct 15; 137(8):2428-33. PMID: 3093576.
      View in: PubMed
    360. Lanier L, Ruitenberg JJ, Allison JP, Weiss A. Distinct epitopes on the T cell antigen receptor of HPB-ALL tumor cells identified by monoclonal antibodies. J Immunol. 1986 Oct 1; 137(7):2286-92. PMID: 2428866.
      View in: PubMed
    361. Phillips JH, Lanier L. Dissection of the lymphokine-activated killer phenomenon. Relative contribution of peripheral blood natural killer cells and T lymphocytes to cytolysis. J Exp Med. 1986 Sep 1; 164(3):814-25. PMID: 3489062; PMCID: PMC2188384.
    362. Lanier L, Ruitenberg JJ, Phillips JH. Human CD3+ T lymphocytes that express neither CD4 nor CD8 antigens. J Exp Med. 1986 Jul 1; 164(1):339-44. PMID: 2425030; PMCID: PMC2188194.
    363. Lanier L, Le AM, Civin CI, Loken MR, Phillips JH. The relationship of CD16 (Leu-11) and Leu-19 (NKH-1) antigen expression on human peripheral blood NK cells and cytotoxic T lymphocytes. J Immunol. 1986 Jun 15; 136(12):4480-6. PMID: 3086432.
      View in: PubMed
    364. Lanier L, Phillips JH. Evidence for three types of human cytotoxic lymphocyte. Immunol Today. 1986 May; 7(5):132-4. PMID: 25290000.
      View in: PubMed
    365. Sriram S, Lanier L. NK cell function in a patient with IgM monoclonal antibody against myelin-associated glycoprotein. Neurology. 1986 Apr; 36(4):566-8. PMID: 2421200.
      View in: PubMed
    366. Clayberger C, Dyer B, McIntyre B, Koller TD, Hardy B, Parham P, Lanier L, Krensky AM. Function and cell distribution of KC-1, a novel natural killer cell-associated antigen. J Immunol. 1986 Mar 1; 136(5):1537-41. PMID: 3081628.
      View in: PubMed
    367. Phillips JH, Lanier L. Lectin-dependent and anti-CD3 induced cytotoxicity are preferentially mediated by peripheral blood cytotoxic T lymphocytes expressing Leu-7 antigen. J Immunol. 1986 Mar 1; 136(5):1579-85. PMID: 2419407.
      View in: PubMed
    368. Lanier L, Phillips JH. Human thymic and peripheral blood non-MHC-restricted cytotoxic lymphocytes. Med Oncol Tumor Pharmacother. 1986; 3(3-4):247-54. PMID: 2433552.
      View in: PubMed
    369. Lanier L, Cwirla S, Federspiel N, Phillips JH. Human natural killer cells isolated from peripheral blood do not rearrange T cell antigen receptor beta chain genes. J Exp Med. 1986 Jan 1; 163(1):209-14. PMID: 3484512; PMCID: PMC2188004.
    370. Lanier L, Phillips JH. Ontogeny of natural killer cells. Nature. 1986 Jan 23-29; 319(6051):269-70. PMID: 3484543.
      View in: PubMed
    371. Lanier L, Kipps TJ, Phillips JH. Functional properties of a unique subset of cytotoxic CD3+ T lymphocytes that express Fc receptors for IgG (CD16/Leu-11 antigen). J Exp Med. 1985 Dec 1; 162(6):2089-106. PMID: 2415663; PMCID: PMC2187997.
    372. Allison JP, McIntyre BW, Ridge LL, Gross-Pelose J, Lanier L. Molecular characterization of the murine T cell antigen receptor and associated structures. Fed Proc. 1985 Oct; 44(13):2870-3. PMID: 2412897.
      View in: PubMed
    373. Lanier L. Lymphocyte surface antigens. Introduction. Fed Proc. 1985 Oct; 44(13):2863-4. PMID: 2864288.
      View in: PubMed
    374. Strassmann G, Springer TA, Haskill SJ, Miraglia CC, Lanier L, Adams DO. Antigens associated with the activation of murine mononuclear phagocytes in vivo: differential expression of lymphocyte function-associated antigen in the several stages of development. Cell Immunol. 1985 Aug; 94(1):265-75. PMID: 3893748.
      View in: PubMed
    375. Ault KA, Lanier L. Terminology in T gamma lymphoproliferative disease. Blood. 1985 Jul; 66(1):248-9. PMID: 3873971.
      View in: PubMed
    376. Lanier L, Arnaout MA, Schwarting R, Warner NL, Ross GD. p150/95, Third member of the LFA-1/CR3 polypeptide family identified by anti-Leu M5 monoclonal antibody. Eur J Immunol. 1985 Jul; 15(7):713-8. PMID: 3924634.
      View in: PubMed
    377. Fox RI, Hugli TE, Lanier L, Morgan EL, Howell F. Salivary gland lymphocytes in primary Sjogren's syndrome lack lymphocyte subsets defined by Leu-7 and Leu-11 antigens. J Immunol. 1985 Jul; 135(1):207-14. PMID: 3923102.
      View in: PubMed
    378. Phillips JH, Lanier L. A model for the differentiation of human natural killer cells. Studies on the in vitro activation of Leu-11+ granular lymphocytes with a natural killer-sensitive tumor cell, K562. J Exp Med. 1985 Jun 1; 161(6):1464-82. PMID: 3159818; PMCID: PMC2187621.
    379. Allison JP, Lanier L. Identification of antigen receptor-associated structures on murine T cells. Nature. 1985 Mar 7-13; 314(6006):107-9. PMID: 2579338.
      View in: PubMed
    380. Lanier L, Benike CJ, Phillips JH, Engleman EG. Recombinant interleukin 2 enhanced natural killer cell-mediated cytotoxicity in human lymphocyte subpopulations expressing the Leu 7 and Leu 11 antigens. J Immunol. 1985 Feb; 134(2):794-801. PMID: 3871216.
      View in: PubMed
    381. Green PL, Lamph WW, Dudley J, Arfsten A, Risser R, Lanier L, Warner NL, Tung JS, Scheid MP. Phenotypic variation in clonal Abelson virus lymphoma cells. J Immunol. 1985 Feb; 134(2):1268-75. PMID: 2856928.
      View in: PubMed
    382. Waldor MK, Sriram S, Hardy R, Herzenberg LA, Herzenberg LA, Lanier L, Lim M, Steinman L. Reversal of experimental allergic encephalomyelitis with monoclonal antibody to a T-cell subset marker. Science. 1985 Jan 25; 227(4685):415-7. PMID: 3155574.
      View in: PubMed
    383. Krensky AM, Lanier L, Engleman EG. Lymphocyte subsets and surface molecules in man. Clin Immunol Rev. 1985; 4(1):95-138. PMID: 2992859.
      View in: PubMed
    384. Prince HE, Hirji K, Waldbeser LS, Plaeger-Marshall S, Kleinman S, Lanier L. Influence of racial background on the distribution of T-cell subsets and Leu 11-positive lymphocytes in healthy blood donors. Diagn Immunol. 1985; 3(1):33-7. PMID: 3158465.
      View in: PubMed
    385. Allison JP, Ridge L, Lund J, Gross-Pelose J, Lanier L, McIntyre BW. The murine T cell antigen receptor and associated structures. Immunol Rev. 1984 Oct; 81:145-60. PMID: 6210241.
      View in: PubMed
    386. Chen YX, Evans RL, Pollack MS, Lanier L, Phillips JH, Rousso C, Warner NL, Brodsky FM. Characterization and expression of the HLA-DC antigens defined by anti-Leu 10. Hum Immunol. 1984 Aug; 10(4):221-35. PMID: 6332101.
      View in: PubMed
    387. Perussia B, Trinchieri G, Jackson A, Warner NL, Faust J, Rumpold H, Kraft D, Lanier L. The Fc receptor for IgG on human natural killer cells: phenotypic, functional, and comparative studies with monoclonal antibodies. J Immunol. 1984 Jul; 133(1):180-9. PMID: 6233371.
      View in: PubMed
    388. Basham T, Smith W, Lanier L, Morhenn V, Merigan T. Regulation of expression of class II major histocompatibility antigens on human peripheral blood monocytes and Langerhans cells by interferon. Hum Immunol. 1984 Jun; 10(2):83-93. PMID: 6203882.
      View in: PubMed
    389. Phillips JH, Le AM, Lanier L. Natural killer cells activated in a human mixed lymphocyte response culture identified by expression of Leu-11 and class II histocompatibility antigens. J Exp Med. 1984 Apr 1; 159(4):993-1008. PMID: 6231353; PMCID: PMC2187263.
    390. Lanier L, Phillips JH, Warner NL, Babcock GF. A human natural killer cell-associated antigen defined by monoclonal antibody anti-Leu (NKP-15): functional and two-color flow cytometry analysis. J Leukoc Biol. 1984 Jan; 35(1):11-7. PMID: 6608568.
      View in: PubMed
    391. Hogarth PM, McKenzie IF, Lanier L, Bailey DW, Taylor BA. Location of Ly-7 on mouse chromosome 12. Immunogenetics. 1984; 19(6):539-43. PMID: 6735449.
      View in: PubMed
    392. Lanier L, Loken MR. Human lymphocyte subpopulations identified by using three-color immunofluorescence and flow cytometry analysis: correlation of Leu-2, Leu-3, Leu-7, Leu-8, and Leu-11 cell surface antigen expression. J Immunol. 1984 Jan; 132(1):151-6. PMID: 6361119.
      View in: PubMed
    393. Lanier L, Le AM, Phillips JH, Warner NL, Babcock GF. Subpopulations of human natural killer cells defined by expression of the Leu-7 (HNK-1) and Leu-11 (NK-15) antigens. J Immunol. 1983 Oct; 131(4):1789-96. PMID: 6225799.
      View in: PubMed
    394. Lanier L, Warner NL. Lym 7.3: new murine specificity defining third allele of the Ly 7 locus. Hybridoma. 1983; 2(2):177-85. PMID: 6205975.
      View in: PubMed
    395. Lanier L, Engleman EG, Gatenby P, Babcock GF, Warner NL, Herzenberg LA. Correlation of functional properties of human lymphoid cell subsets and surface marker phenotypes using multiparameter analysis and flow cytometry. Immunol Rev. 1983; 74:143-60. PMID: 6226586.
      View in: PubMed
    396. Phillips JH, Warner NL, Lanier L. Correlation of biophysical properties and cell surface antigenic profile of Percoll gradient-separated human natural killer cells. Nat Immun Cell Growth Regul. 1983-1984; 3(2):73-86. PMID: 6092949.
      View in: PubMed
    397. Lanier L, Richie ER, Howell AL, Allison JP. Expression of Ly-1 and Ly-2 on a spontaneous AKR B-cell lymphoma. Immunogenetics. 1983; 17(6):655-9. PMID: 6602763.
      View in: PubMed
    398. Lanier L. Activation of murine B cell lymphomas. I. Influence of lipopolysaccharide. J Immunol. 1982 Sep; 129(3):1130-7. PMID: 6980920.
      View in: PubMed
    399. Walker EB, Lanier L, Warner NL. Concomitant induction of the cell surface expression of Ia determinants and accessory cell function by a murine macrophage tumor cell line. J Exp Med. 1982 Feb 1; 155(2):629-34. PMID: 6173461; PMCID: PMC2186587.
    400. Walker EB, Lanier L, Warner NL. Characterization and functional properties of tumor cell lines in accessory cell replacement assays. J Immunol. 1982 Feb; 128(2):852-9. PMID: 7033383.
      View in: PubMed
    401. Lanier L, Gutman GA, Lewis DE, Griswold ST, Warner NL. Monoclonal antibodies against rat immunoglobulin kappa chains. Hybridoma. 1982; 1(2):125-31. PMID: 6821397.
      View in: PubMed
    402. Lanier L, Warner NL. Lym 7.2: monoclonal antibody defining an alloantigen similar or identical to Ly 7.2. Hybridoma. 1982; 1(3):227-41. PMID: 6208126.
      View in: PubMed
    403. Lanier L, Arnold LW, Raybourne RB, Russell S, Lynes MA, Warner NL, Haughton G. Transplantable B-cell lymphomas in B10. H-2aH-4bp/Wts mice. Immunogenetics. 1982; 16(4):367-71. PMID: 6983495.
      View in: PubMed
    404. Lanier L, Warner NL, Ledbetter JA, Herzenberg LA. Quantitative immunofluorescent analysis of surface phenotypes of murine B cell lymphomas and plasmacytomas with monoclonal antibodies. J Immunol. 1981 Oct; 127(4):1691-7. PMID: 7024413.
      View in: PubMed
    405. Lanier L, Warner NL, Ledbetter JA, Herzenberg LA. Expression of Lyt-1 antigen on certain murine B cell lymphomas. J Exp Med. 1981 Apr 1; 153(4):998-1003. PMID: 6788882; PMCID: PMC2186138.
    406. Lanier L, Warner NL. Cell cycle related heterogeneity of Ia antigen expression on a murine B lymphoma cell line:analysis by flow cytometry. J Immunol. 1981 Feb; 126(2):626-31. PMID: 6969756.
      View in: PubMed
    407. Lanier L, Warner NL. Paraformaldehyde fixation of hematopoietic cells for quantitative flow cytometry (FACS) analysis. J Immunol Methods. 1981; 47(1):25-30. PMID: 7310138.
      View in: PubMed
    408. Lanier L, Babcock GF, Raybourne RB, Arnold LW, Warner NL, Haughton G. Mechanism of B cell lymphoma immunotherapy with passive xenogeneic anti-idiotype serum. J Immunol. 1980 Oct; 125(4):1730-6. PMID: 6997386.
      View in: PubMed
    409. Lanier L, Babcock GF, Lynes MA, Haughton G. Antigen-induced murine B-cell lymphomas. III. Passive anti-idiotype serum therapy and its combined effect with chemotherapy. J Natl Cancer Inst. 1979 Dec; 63(6):1417-22. PMID: 316036.
      View in: PubMed
    410. Lanier L, Babcock GF, Lynes MA, Haughton G. Early detection of the CH1 murine lymphoma by tumor-associated idiotype in the serum. Int J Cancer. 1979 Jul 15; 24(1):53-9. PMID: 314422.
      View in: PubMed
    411. Lanier L, Haughton G. Tolerance to non-H-2 histocompatibility antigens. Transplantation tolerance to the H-4 and H-7 histocompatibility antigens. Transplantation. 1979 Mar; 27(3):208-11. PMID: 373182.
      View in: PubMed
    412. Lynes MA, Lanier L, Babcock GF, Wettstein PJ, Haughton G. Antigen-induced murine B cell lymphomas. I. Induction and characterization of CH1 and CH2. J Immunol. 1978 Dec; 121(6):2352-7. PMID: 363945.
      View in: PubMed
    413. Haughton G, Lanier L, Babcock GF, Lynes MA. Antigen-induced murine B cell lymphomas. II. Exploitation of the surface idiotype as tumor specific antigen. J Immunol. 1978 Dec; 121(6):2358-62. PMID: 82581.
      View in: PubMed
    414. Haughton G, Lanier L, Babcock GF. The murine kappa light chain shift. Nature. 1978 Sep 14; 275(5676):154-7. PMID: 99664.
      View in: PubMed
    415. Lanier L, Lynes M, Haughton G, Wettstein PJ. Novel type of murine B-cell lymphoma. Nature. 1978 Feb 9; 271(5645):554-5. PMID: 304532.
      View in: PubMed
    Lewis's Networks
    Concepts
    Derived automatically from this person's publications.
    _
    Co-Authors
    People in Profiles who have published with this person.
    _
    Related Authors
    People who share related concepts with this person.
    _
    Back to TOP